ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	51/1485	73/6033	3.25524562935037e-16	1.78061935925465e-13	1.46314724603432e-13	6356/6357/6358/6361/6362/6363/6347/6364/6367/6369/6370/10344/6348/6351/9560/6355/1437/1440/6376/2919/3627/6373/284340/2920/2921/6374/6372/4283/10148/3458/3586/3589/3605/3606/29949/3552/3553/3557/51561/11009/90865/3569/4049/4312/4314/4318/5008/5196/6696/7124/10673	51
WP2806	Complement system	47/1485	75/6033	2.40302482444406e-12	6.57227289485451e-10	5.40048210546113e-10	133/335/715/716/717/718/720/722/728/27202/729/811/958/1604/966/22918/629/1675/3426/5199/1378/2159/2160/2214/2219/2357/2769/3383/3384/3673/3687/3689/3690/3818/3911/3915/5648/5329/5806/6401/6402/6403/6404/710/6696/7097/7454	47
WP5055	Burn wound healing	52/1485	97/6033	6.3511055124518e-10	1.15801823843705e-07	9.51551597830498e-08	8038/6347/57124/1139/1265/1277/1278/2919/3579/2006/2200/2261/60674/3082/3383/3552/3553/3569/3624/3791/3853/3956/23643/440823/407024/4312/4322/4313/79148/4314/4318/100463486/64332/64127/5159/6282/6280/6423/6678/6876/7042/7043/7076/7096/7097/7099/51311/54106/3371/7124/7128/7431	52
WP5218	Extrafollicular B cell activation by SARS-CoV-2	39/1485	65/6033	1.16702542093658e-09	1.59590726313077e-07	1.31136803878926e-07	57379/604/718/720/6363/958/969/973/941/3732/1378/10148/2113/83416/1880/29851/3433/8519/3455/3458/100885789/3586/3569/3662/9636/3687/3689/4240/5133/639/5788/6402/57823/6776/30009/7099/7124/10673/7494	39
WP5115	Network map of SARS-CoV-2 signaling pathway	83/1485	190/6033	4.03122039578594e-09	4.41015511298982e-07	3.62385496631705e-07	59272/183/335/350/8542/332/684/11119/715/716/84433/838/841/6356/6347/6364/6367/10344/6348/6351/6355/891/10666/983/1051/629/3426/5199/1294/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/54541/84985/2247/2534/51512/3091/3122/3123/3429/10964/8519/10410/3458/3486/3586/3605/3606/8807/3552/3553/90865/3569/10379/3699/3717/3726/116844/64386/4791/22861/114548/4939/5196/5743/6241/6288/6289/6403/5054/6772/7124/7173/7216/7535	83
WP3624	Lung fibrosis	32/1485	52/6033	1.54084233467902e-08	1.4047345951157e-06	1.15428013492621e-06	23250/6356/6347/6348/6351/729230/1232/1051/1437/1440/2920/57105/1906/2006/2246/2247/2252/26585/3082/3553/3569/4313/4318/4502/5155/5328/5806/6498/6696/7015/7076/7124	32
WP2865	IL1 and megakaryocytes in obesity	18/1485	23/6033	9.22458623115904e-08	7.20835524063428e-06	5.92315536948107e-06	6347/1232/2149/2205/1839/3383/3458/3606/3553/3554/4318/114548/7941/6280/8991/7076/7096/7097	18
WP2911	miRNA targets in ECM and membrane receptors	17/1485	22/6033	2.97080411585159e-07	2.03128731421352e-05	1.66912283877451e-05	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/3672/22801/3694/3910/3913/3915/7058	17
WP2328	Allograft rejection	39/1485	76/6033	4.12977098635269e-07	2.50998303281658e-05	2.06247042242409e-05	5243/185/23743/717/718/720/721/729/841/6363/940/958/1604/941/942/1289/1493/6373/4283/50943/10578/3002/3108/3112/3119/3122/3123/3134/3458/3586/3605/3552/3553/3559/120892/5551/6772/7124/7431	39
WP2877	Vitamin D receptor pathway	62/1485	143/6033	5.33319265943788e-07	2.91725638471252e-05	2.39712975324208e-05	5243/11096/147/240/248/604/768/838/875/898/958/1029/1030/634/9075/1493/1594/1559/1565/29785/1576/168002/1673/11221/1946/50486/727936/3091/3123/3294/3486/3488/9173/3662/3684/3726/5653/3827/126364/4600/5368/639/5744/10125/6273/6279/6280/1992/10568/219855/25928/6696/6699/79689/412/6822/7042/7056/7078/7128/4982/54210	62
WP558	Complement and coagulation cascades	28/1485	48/6033	6.04007430101242e-07	3.00356422059436e-05	2.46804949907397e-05	715/716/717/718/721/728/729/1604/629/1675/3426/1191/1378/2159/2149/2152/2155/3818/3827/5648/5328/5329/5624/5054/5345/710/7056/7450	28
WP619	Type II interferon signaling	22/1485	34/6033	8.2603309827608e-07	3.76533420630846e-05	3.09400116634988e-05	4261/3627/4283/1536/2633/3383/3433/3458/3553/3659/3662/10379/9636/3717/4843/5698/5967/8651/9021/6688/6772/6890	22
WP5198	Inflammatory bowel disease signaling	22/1485	35/6033	1.70930670197647e-06	7.19223666139332e-05	5.90991062140854e-05	50943/3108/3458/3586/3594/3595/3606/8807/3552/50615/51561/3569/4772/64127/6097/6772/6774/6775/30009/7097/7099/7124	22
WP5090	Complement system in neuronal development and plasticity	43/1485	93/6033	3.99352641413995e-06	0.000156032782038182	0.000128213216453967	57194/23250/57198/148229/715/716/717/718/720/721/722/725/728/27202/729/843/841/1604/966/629/1675/3426/5199/1191/10584/1378/286204/6376/9787/2219/8547/3458/3684/3685/3687/3689/3690/5648/4240/5359/710/7042/7043	43
WP455	GPCRs, class A rhodopsin-like	51/1485	118/6033	6.05556642574164e-06	0.000220826322325378	0.000181454516757311	1238/51554/134/147/150/185/187/27202/1230/729230/1232/1233/1237/10803/1131/3577/3579/2833/10800/57105/1909/2149/2151/9002/2867/2357/2358/2842/2828/8477/8111/54329/8843/3274/3363/1241/4543/5540/27334/53829/9934/5030/5031/5724/5729/5737/5739/266747/6751/6752/56670	51
WP4891	COVID-19 adverse outcome pathway	11/1485	13/6033	9.17487399535307e-06	0.000302836416171947	0.00024884277822654	59272/183/6347/6348/1440/3627/3586/3553/3559/3569/7124	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	13/1485	17/6033	9.96536652851013e-06	0.000302836416171947	0.00024884277822654	6347/958/3383/3553/5196/6401/6403/6404/7042/7043/7097/7099/7412	13
WP691	Tamoxifen metabolism	13/1485	17/6033	9.96536652851013e-06	0.000302836416171947	0.00024884277822654	1545/1557/1558/1559/1565/1576/2326/2328/6817/6822/54575/54657/7364	13
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	96/1485	265/6033	1.0750752770837e-05	0.000309508513981466	0.000254325287154981	10000/285/1101/1302/1277/1278/1280/1281/1282/1284/1286/1289/1290/50509/1292/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2246/2255/2259/2247/2252/2254/2261/2321/2324/2690/2784/59345/51764/2786/3082/3091/7184/3455/3559/3560/3563/3575/22801/3673/3678/3655/3679/8516/3683/3685/3687/3689/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/23566/4843/4846/5008/9180/5155/5159/5209/5210/5228/23035/5293/23533/10891/5522/5523/5618/6513/6514/6515/6696/7010/7058/3371/7424/7450	96
WP453	Inflammatory response pathway	17/1485	26/6033	1.24437591690753e-05	0.000340336813274208	0.000279657113957639	940/958/941/942/1277/1278/1281/3458/3559/3560/3568/3911/3913/3915/3918/7133/7535	17
WP129	Matrix metalloproteinases	16/1485	24/6033	1.56831242039033e-05	0.000408508044739766	0.000335673886469509	4312/4319/4321/4322/4323/4327/4313/10893/64386/79148/4314/4316/4318/7076/7078/7124	16
WP4493	Cells and molecules involved in local acute inflammatory response 	12/1485	16/6033	3.13605717791228e-05	0.000757733695985134	0.000622635020082079	718/729/3383/3552/3569/3683/3689/3827/6403/6404/7124/7412	12
WP2882	Nuclear receptors meta-pathway	95/1485	268/6033	3.26155446286375e-05	0.000757733695985134	0.000622635020082079	5243/1244/64240/64241/51/177/51129/335/345/8553/330/874/6347/6364/983/8824/23491/1545/1557/1559/1576/1551/66002/1907/54566/1969/2168/9982/2289/2938/2939/2947/2949/1839/3082/3458/3589/3553/117283/3726/23764/4199/4240/4791/1728/8431/9971/9970/3084/5105/5142/5155/5166/5460/10891/9588/22949/5743/6286/6319/6397/5272/1836/6513/6514/6515/11182/29986/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/8140/5552/27286/6774/2040/6817/6822/7042/7056/7124/7128/84951/1831/54657/54578/7364	95
WP5063	FOXP3 in COVID-19	11/1485	14/6033	3.32460853814319e-05	0.000757733695985134	0.000622635020082079	940/941/942/50943/3559/3560/3569/3572/3575/6774/6776	11
WP5088	Prostaglandin signaling	17/1485	28/6033	5.09045728594344e-05	0.00111379205416442	0.000915210636251726	834/6347/6348/729230/940/2919/3627/4283/3458/3605/3552/3553/3569/4318/114548/9536/7124	17
WP530	Cytokines and inflammatory response	13/1485	19/6033	6.81334275509625e-05	0.00143342249501448	0.00117785318073931	1437/1440/2919/2920/3122/3123/3458/3586/3589/3552/3553/3569/7124	13
WP4172	PI3K-Akt signaling pathway	97/1485	280/6033	7.54308765916299e-05	0.00152817368502302	0.00125571088906924	10000/285/672/898/1101/1277/1278/1280/1282/1284/1286/1291/1292/1293/256076/131873/1297/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2246/2255/2259/2247/2252/2254/2261/2321/2324/2690/2784/59345/10681/51764/2786/3082/7184/3455/3559/3560/3563/3569/3575/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/23566/4846/5008/9180/5105/5155/5159/5228/23035/118788/5293/8503/23533/29941/5522/5523/5618/10110/6696/7010/7058/7097/7099/3371/7424/7450	97
WP4494	Selective expression of chemokine receptors during T-cell polarization	15/1485	24/6033	8.90618705356342e-05	0.00173988725653543	0.00142967739544044	6348/6351/1230/729230/1232/1233/940/1437/2833/3458/3594/3595/8809/7042/7043	15
WP2849	Hematopoietic stem cell differentiation	23/1485	46/6033	0.000166447179183667	0.00305177382476759	0.00250766366434285	91/947/4261/1437/1440/10320/3552/3553/3569/3690/51176/4005/4582/3071/4778/399/23541/6688/6776/7068/7173/23650/7409	23
WP4969	RAS and bradykinin pathways in COVID-19	15/1485	25/6033	0.00017220369020606	0.00305177382476759	0.00250766366434285	1636/59272/183/185/1576/3552/3553/3816/3818/3827/4846/4881/5054/710/7124	15
WP4538	Regulatory circuits of the STAT3 signaling pathway	33/1485	75/6033	0.000172952447107487	0.00305177382476759	0.00250766366434285	185/1271/1438/1439/1441/1844/2149/2151/9002/2690/3455/3587/3595/3601/50615/9466/3559/3560/3563/3568/3572/3575/3717/3718/5600/6300/9180/5159/5579/5788/80854/9021/6774	33
WP5033	Genes associated with the development of rheumatoid arthritis	12/1485	18/6033	0.000192574296874613	0.00319206486031556	0.00262294177880255	958/4261/1493/3123/3559/3572/3685/23569/26147/6583/6775/7185	12
WP545	Complement activation	12/1485	18/6033	0.000192574296874613	0.00319206486031556	0.00262294177880255	715/716/717/718/720/721/729/1604/629/1675/5199/5648	12
WP3617	Photodynamic therapy-induced NF-kB survival signaling	18/1485	33/6033	0.000210222791833877	0.00338211373920973	0.00277910625737045	597/330/332/1437/2920/3383/3552/3553/3569/4312/4313/4314/4318/4791/5743/6401/7124/7412	18
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	16/1485	28/6033	0.000230977003335743	0.00360984059499004	0.00296623099020638	6347/29126/941/942/1493/3627/3559/3560/4791/5133/8651/6774/7042/7043/7099/51311	16
WP3937	Microglia pathogen phagocytosis pathway	20/1485	39/6033	0.000285773599284897	0.0043421710780233	0.00356799201446348	10095/1536/2207/2209/3055/3684/3689/4067/653361/4688/4689/3071/5293/8503/5336/5880/27036/54210/7409/10451	20
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	22/1485	45/6033	0.0003467898032961	0.00512686547035046	0.00421278082524708	2180/2182/9023/1593/1718/1717/54898/60481/3992/9415/2222/2224/3157/3158/51478/3422/4047/6307/4597/6319/8435/6713	22
WP1604	Codeine and morphine metabolism	8/1485	10/6033	0.000366009358571704	0.00526860839838742	0.00432925196980935	5243/1244/1558/1565/1576/54575/54578/7364	8
WP702	Metapathway biotransformation Phase I and II	48/1485	125/6033	0.00038641850156938	0.00527862216051103	0.00433748034742271	50515/166012/9435/9469/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/54905/1576/1551/66002/8529/260293/9420/2052/2053/2326/2327/2328/2330/9514/79690/92292/2938/2939/2947/2949/9955/90161/8514/9027/339983/4837/6817/6799/6822/54575/54657/54578/79799/7364	48
WP117	GPCRs, other	19/1485	37/6033	0.000395655408740315	0.00527862216051103	0.00433748034742271	27202/1131/3577/3579/2833/1909/2149/29933/4935/11245/1880/53831/59340/3363/59352/53829/5737/1901/6752	19
WP1533	Vitamin B12 metabolism	19/1485	37/6033	0.000395655408740315	0.00527862216051103	0.00433748034742271	335/338/875/6347/8029/2155/3383/3458/3553/3569/3949/4791/6288/6289/5054/6648/6947/6948/7124	19
WP474	Endochondral ossification	26/1485	57/6033	0.00041837180508305	0.00532207854373089	0.00437318875815085	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/5745/5744/864/55553/6696/6772/7042/7078	26
WP4808	Endochondral ossification with skeletal dysplasias	26/1485	57/6033	0.00041837180508305	0.00532207854373089	0.00437318875815085	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/5745/5744/864/55553/6696/6772/7042/7078	26
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	18/1485	35/6033	0.000548260906380505	0.00681587990432127	0.005600655670442	285/597/332/664/1906/3091/3485/3486/3939/4843/5315/5366/5743/5054/6566/6513/6515/7043	18
WP3945	TYROBP causal network in microglia	27/1485	61/6033	0.000588669079520555	0.00715559969994985	0.00587980577673162	54518/718/8832/64764/79690/202309/3059/3142/10261/3587/3606/3684/3687/3689/4688/3071/375387/5341/170954/5996/864/64092/6696/6776/10312/113277/7133	27
WP4754	IL-18 signaling pathway	81/1485	239/6033	0.000638632771368093	0.00749189887545888	0.00615614513580476	35/11096/321/467/330/841/6362/6363/6347/6364/6348/6351/890/9308/1051/1071/9076/24146/6900/1277/1278/1281/2920/2921/1674/1891/2023/338442/3315/26353/3383/8870/3458/3586/3606/8809/8807/3553/3559/3569/3659/3801/10365/4312/4322/4323/4313/4314/4318/653361/4688/4791/64332/4843/8431/3164/7941/5579/5743/5778/5806/6004/8698/9021/6696/341359/6869/30009/7052/7076/7078/55858/7124/7127/7128/4982/79931/7185/10194/80149/51222	81
WP24	Peptide GPCRs	20/1485	41/6033	0.000663780363314307	0.00749189887545888	0.00615614513580476	185/728/1230/729230/1232/1233/1237/10803/3577/3579/2833/10663/1909/2357/2358/5540/6751/6752/6869/7253	20
WP272	Blood clotting cascade	10/1485	15/6033	0.000684817081851817	0.00749189887545888	0.00615614513580476	2159/2160/2152/2155/3816/3818/5328/5054/5345/7450	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	10/1485	15/6033	0.000684817081851817	0.00749189887545888	0.00615614513580476	302/335/338/1071/3949/3990/9388/4023/4547/255738	10
WP5109	Familial hyperlipidemia type 2	10/1485	15/6033	0.000684817081851817	0.00749189887545888	0.00615614513580476	335/337/338/1071/2053/2690/3949/3990/4023/255738	10
WP3529	Zinc homeostasis	17/1485	33/6033	0.000760470511402219	0.00815641901445126	0.0067021859312435	4489/4493/4494/4495/4496/4500/4499/4501/4502/4504/55532/7780/7782/169026/29986/55630/283375	17
WP3929	Chemokine signaling pathway	55/1485	152/6033	0.000842715531486573	0.00886471914852222	0.00728420105151349	196883/10000/6356/6361/6363/6364/6367/6369/6370/10344/6348/6351/1230/729230/1232/1233/1237/10803/6376/3627/6373/2921/6374/4283/3579/2833/10663/1794/9844/2268/2784/59345/10681/51764/2786/2869/3055/3702/3717/3718/4067/653361/5196/5293/8503/23533/23236/5579/5880/25759/6772/6774/7409/10451/7454	55
WP5097	CCL18 signaling pathway	19/1485	39/6033	0.000919418192360964	0.00948908964568768	0.00779725060850311	467/1237/960/1278/1437/3091/3939/440823/4313/4318/6513/6615/6772/7004/7020/7291/7412/7424/7431	19
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	27/1485	63/6033	0.00107994571132618	0.0109394500758411	0.00898902180772475	59272/841/6347/6348/6351/11126/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3433/8519/3455/3586/3569/3902/5196/6772/7020/7124	27
WP2431	Spinal cord injury	38/1485	98/6033	0.00122434293281272	0.0121766469863374	0.0100056350681537	301/63827/6347/729230/983/50515/1280/1282/1464/2919/3627/2920/2212/2697/3383/3458/3552/3553/3554/3569/10288/11025/1241/4321/4318/4843/3164/5320/5362/5743/6098/6403/57556/6869/7099/7124/10673/7431	38
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	18/1485	37/6033	0.00127467692048395	0.0124508620625843	0.0102309594933581	9744/9447/84674/834/838/841/50506/3606/3553/4210/58484/22861/91662/114548/199713/64127/639/8767	18
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	47/1485	128/6033	0.00137541516749514	0.0131991595898218	0.0108458407482996	116/8553/720/721/1051/1103/1139/1141/1390/1644/54738/2328/2305/2697/2784/3091/7184/3359/3586/3552/3553/3557/3569/3764/4128/4760/4791/4821/4824/5354/5452/5460/10891/5577/864/6507/6532/6616/6750/6751/6752/6869/7068/7124/7161/7166/7433	47
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	13/1485	24/6033	0.00176129815268523	0.0166108636123935	0.0136492615462177	51/8309/246/240/66002/8529/10800/57105/1800/2358/1241/22949/8989	13
WP43	Oxidation by cytochrome P450	18/1485	38/6033	0.00187223855891263	0.0172420233233458	0.0141678898471446	51700/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/54905/1576/1551/66002/8529/260293/9420	18
WP4210	Tryptophan catabolism leading to NAD+ production	9/1485	14/6033	0.00189126398427925	0.0172420233233458	0.0141678898471446	23498/3620/8564/8942/10135/23057/349565/23475/6999	9
WP3892	Development of pulmonary dendritic cells and macrophage subsets	8/1485	12/6033	0.00247453057098383	0.0221896429889861	0.0182333831546177	55509/1437/10320/3662/6688/6774/6925/7173	8
WP430	Statin inhibition of cholesterol production	13/1485	25/6033	0.00285130636563536	0.0250635586373304	0.0205948995249496	64240/64241/335/337/338/345/1071/2222/3949/3990/4023/4547/6713	13
WP5094	Orexin receptor pathway	41/1485	112/6033	0.00288666214652983	0.0250635586373304	0.0205948995249496	8553/2920/1734/1846/1959/1960/2324/84264/1839/3091/8091/9456/3309/3383/3586/3553/3569/3726/3777/3939/3949/4023/84230/23764/7873/4322/4314/4846/3164/8013/26031/5069/5163/6241/6401/6498/6513/6696/3371/7124/7412	41
WP197	Cholesterol biosynthesis pathway	9/1485	15/6033	0.00370093433792041	0.0316314231694135	0.0259917592482239	1717/2222/2224/3157/3422/4047/6307/4597/6713	9
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	27/1485	68/6033	0.00406282060991524	0.0341901980557483	0.0280943222742317	816/857/6347/958/1594/1673/2113/10964/3458/3569/9636/5600/6300/4791/64127/4939/23236/5333/5336/5579/91543/6258/6772/7097/7099/51311/7124	27
WP2880	Glucocorticoid receptor pathway	26/1485	65/6033	0.00423710440233191	0.0351166076981144	0.0288555594863752	51129/8553/330/6347/6364/1907/54566/9982/3589/4240/8972/4791/9970/5142/5460/5743/6286/6397/5272/1836/5552/2040/7056/7128/84951/1831	26
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	13/1485	26/6033	0.00443390048819687	0.03619915771707	0.0297450983261597	51/8309/66002/8529/5729/5730/9536/5737/5739/5740/22949/5743/6916	13
WP15	Selenium micronutrient network	24/1485	59/6033	0.00457418602821855	0.0367952905505227	0.0302349447995251	240/335/338/875/6347/1734/1735/2155/3383/3458/3553/3569/8564/8942/3949/4791/10549/5743/6288/6289/5054/6648/7124/7498	24
WP5193	Cholesterol synthesis disorders	10/1485	18/6033	0.00474818262506719	0.0376413897958225	0.0309301904028023	1718/1717/2222/2224/3157/3422/4047/6307/4597/6713	10
WP4724	Omega-9 fatty acid synthesis	8/1485	13/6033	0.00505184214229243	0.0394765378833422	0.0324381442820882	2180/2182/54898/60481/79071/3992/9415/6319	8
WP3942	PPAR signaling pathway	22/1485	54/6033	0.00635421977950479	0.0489543411181566	0.040226120768696	51/8309/2180/2182/51129/335/345/364/126129/1593/2168/2172/9415/3158/4023/4199/4312/4973/5105/6258/6319/28965	22
WP247	Small ligand GPCRs	9/1485	16/6033	0.00662769788522069	0.0489912262596719	0.0402564295446548	4543/5724/5729/5737/5739/1901/9294/1903/8698	9
WP4478	LTF danger signal response pathway	9/1485	16/6033	0.00662769788522069	0.0489912262596719	0.0402564295446548	177/3552/3553/3569/4057/7097/7099/7124/54210	9
WP516	Hypertrophy model	9/1485	16/6033	0.00662769788522069	0.0489912262596719	0.0402564295446548	467/11072/1839/3458/3606/3552/3554/8013/6935	9
WP229	Irinotecan pathway	7/1485	11/6033	0.00684924667688402	0.0499538390967408	0.0410474151723435	4363/1244/9429/590/8824/1576/54575	7
WP465	Tryptophan metabolism	15/1485	33/6033	0.00710908051100663	0.0508186052749381	0.0417579995235227	8854/316/1545/1573/1576/66002/9420/1644/1718/23498/3620/8942/4129/6999/7166	15
WP4329	miRNAs involvement in the immune response in sepsis	17/1485	39/6033	0.0071536245085379	0.0508186052749381	0.0417579995235227	6348/6351/3002/3383/3586/3552/3569/3659/3934/114614/407008/407024/4791/7099/51311/7124/7412	17
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	11/1485	22/6033	0.00871426093528389	0.0611115478410293	0.0502157816378707	2919/2920/2247/3553/4821/5155/5354/6469/6663/55553/7124	11
WP697	Estrogen metabolism	8/1485	14/6033	0.00926594635297667	0.0636319184607687	0.0522867876123319	1545/1576/2938/1728/412/6817/54578/7364	8
WP5092	Interactions of natural killer cells in pancreatic cancer	12/1485	25/6033	0.00930631348603565	0.0636319184607687	0.0522867876123319	6347/6348/6351/10666/1437/2214/3002/3458/4277/5551/201633/7124	12
WP2848	Pluripotent stem cell differentiation pathway	15/1485	34/6033	0.00988134825242029	0.0667295986922703	0.054832172888674	3577/22943/2246/2255/2247/3082/3589/3569/3624/5155/6469/7043/7173/7472/7474	15
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	9/1485	17/6033	0.0110453256958541	0.0736804043369779	0.0605436979734236	249/1594/5167/56975/2261/4791/6098/142680/6696	9
WP167	Eicosanoid synthesis	10/1485	20/6033	0.0122703946063157	0.079903641067318	0.0656573746478298	246/240/1800/5320/80339/5730/9536/5740/5743/6916	10
WP5044	Kynurenine pathway and links to cell senescence	10/1485	20/6033	0.0122703946063157	0.079903641067318	0.0656573746478298	23498/3620/169355/3458/8564/8942/23475/6999/7099/7124	10
WP98	Prostaglandin synthesis and regulation	17/1485	41/6033	0.0127810893476525	0.0815712129442979	0.0670276299956032	301/302/306/307/308/1906/1909/3290/10891/5729/5730/9536/5737/5739/5740/5743/6916	17
WP4495	IL-10 anti-inflammatory signaling pathway 	7/1485	12/6033	0.0129738492251443	0.0815712129442979	0.0670276299956032	644/3586/3587/3552/3569/6772/6774	7
WP5110	Familial hyperlipidemia type 3	7/1485	12/6033	0.0129738492251443	0.0815712129442979	0.0670276299956032	335/337/1071/3949/3990/4023/7436	7
WP4545	Oxysterols derived from cholesterol	14/1485	32/6033	0.0136195665238438	0.0838995240435445	0.068940819333385	134526/23597/8309/23600/9023/1593/1576/9420/1717/2053/1880/3605/3638/6097	14
WP2876	Pregnane X receptor pathway	13/1485	29/6033	0.013650928043648	0.0838995240435445	0.068940819333385	5243/1244/1557/1559/1576/1551/66002/2939/10891/27286/6822/54657/54578	13
WP5174	Ulcerative colitis signaling	8/1485	15/6033	0.0156259600844696	0.0949711129578317	0.0780384205388129	50943/3108/3458/3586/4772/64127/7097/7124	8
WP306	Focal adhesion	58/1485	183/6033	0.0167416027680314	0.10063359026498	0.0826913173157825	10000/330/857/1101/1277/1278/1280/1282/1284/1286/1290/50509/1292/2268/2316/2318/2321/2534/3055/3082/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3791/284217/3909/3910/3911/3913/3915/3918/10319/29780/64098/5155/5159/5228/5293/8503/5579/5880/25759/6696/10420/7058/3371/7409/10451/7424/7450/7791	58
WP497	Urea cycle and metabolism of amino groups	9/1485	18/6033	0.017342468766641	0.102364665323317	0.0841137536669997	445/1152/2628/162417/4942/4953/5009/5831/6723	9
WP2884	NRF2 pathway	39/1485	116/6033	0.0174038644882422	0.102364665323317	0.0841137536669997	1244/177/874/8824/23491/1969/2938/2939/2947/2949/1839/3082/23764/4199/1728/3084/5155/9588/22949/6513/6514/6515/11182/29986/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/7042/54657/54578/7364	39
WP2875	Constitutive androstane receptor pathway	12/1485	27/6033	0.0189465742009871	0.109092379873052	0.0896419632556397	5243/1244/1557/1559/1576/2939/9970/10891/6817/6822/54657/54578	12
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	12/1485	27/6033	0.0189465742009871	0.109092379873052	0.0896419632556397	59272/6347/2939/2977/3553/3569/4312/4314/1728/5593/23657/7124	12
WP2289	Drug induction of bile acid pathway	7/1485	13/6033	0.0222161908218047	0.124002616117624	0.101893807528578	5243/1244/1576/9971/9970/123264/6822	7
WP4723	Omega-3 / omega-6 fatty acid synthesis	7/1485	13/6033	0.0222161908218047	0.124002616117624	0.101893807528578	51/2180/2182/54898/60481/3992/9415	7
WP5108	Familial  hyperlipidemia type 1	7/1485	13/6033	0.0222161908218047	0.124002616117624	0.101893807528578	51129/335/337/1071/3949/3990/4023	7
WP716	Vitamin A and carotenoid metabolism	14/1485	34/6033	0.0243915596878152	0.134769526759949	0.110741052490134	64240/64241/8854/1381/1382/56603/4023/9227/29881/5915/5948/6258/195814/6817	14
WP4541	Hippo-Merlin signaling dysregulation	34/1485	101/6033	0.0247474476539547	0.135368538667132	0.111233264718302	84962/960/1009/1014/1001/1003/1004/3627/1969/2261/2321/2324/2305/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/3791/26524/5159/5577/6788/7004/7010	34
WP3613	Photodynamic therapy-induced unfolded protein response	11/1485	25/6033	0.0263290643821484	0.142594041752823	0.117170510590697	440/467/811/51726/4189/9695/121506/7184/3309/57761/7494	11
WP5098	T-cell activation SARS-CoV-2	28/1485	81/6033	0.0278107739092306	0.149142091454403	0.122551088330665	84433/6363/940/915/941/942/1029/1493/2534/3122/3123/29851/3455/3458/3594/3595/3605/8809/51561/3717/3937/4049/4772/5293/10125/6775/7124/7535	28
WP2858	Ectoderm differentiation	39/1485	120/6033	0.0301205585225417	0.159960636037187	0.131440761258307	398/170302/91653/6347/1004/5010/1496/1896/54898/2274/2534/2627/57476/9687/152789/3801/3853/9079/4061/4772/22871/5080/345557/5362/5420/5452/5783/114822/6386/5269/6469/6498/7903/6781/7020/4982/54521/7704/51222	39
WP4583	Biomarkers for urea cycle disorders	6/1485	11/6033	0.0317866074244318	0.16413430020962	0.134870289982696	445/2159/2155/2628/162417/5009	6
WP4707	Aspirin and miRNAs	6/1485	11/6033	0.0317866074244318	0.16413430020962	0.134870289982696	283120/114614/4597/4846/5163/5743	6
WP176	Folate metabolism	18/1485	48/6033	0.0318066468413523	0.16413430020962	0.134870289982696	335/338/875/6347/2155/3383/3458/3553/3569/3949/10797/4791/6288/6289/5054/113235/6648/7124	18
WP2879	Farnesoid X receptor pathway	7/1485	14/6033	0.0351664352906328	0.173310278327223	0.142410254682429	1576/2289/117283/8431/9971/10891/6822	7
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	7/1485	14/6033	0.0351664352906328	0.173310278327223	0.142410254682429	3589/3569/3572/3717/3718/6774/6935	7
WP4582	Cancer immunotherapy by CTLA4 blockade	7/1485	14/6033	0.0351664352906328	0.173310278327223	0.142410254682429	940/941/942/1493/3123/5293/8503	7
WP5130	Th17 cell differentiation pathway	22/1485	62/6033	0.0358203956322831	0.173310278327223	0.142410254682429	915/50943/3091/3108/3458/3605/3553/50615/51561/9466/3559/3569/3662/3717/4772/6097/9021/6772/6774/6776/30009/7535	22
WP3893	Development and heterogeneity of the ILC family	10/1485	23/6033	0.0366386193672375	0.173310278327223	0.142410254682429	3458/3605/3606/3553/51561/90865/3569/30009/7124/7704	10
WP4197	Immune response to tuberculosis	10/1485	23/6033	0.0366386193672375	0.173310278327223	0.142410254682429	3437/8519/3455/3659/10379/3717/5696/8651/6772/6890	10
WP4585	Cancer immunotherapy by PD-1 blockade	10/1485	23/6033	0.0366386193672375	0.173310278327223	0.142410254682429	10538/29126/915/3123/3458/4772/5133/80380/6774/7535	10
WP3287	Overview of nanoparticle effects	8/1485	17/6033	0.0366943525840422	0.173310278327223	0.142410254682429	10000/1001/1282/3569/3909/5293/5743/7124	8
WP3967	miR-509-3p alteration of YAP1/ECM axis	8/1485	17/6033	0.0366943525840422	0.173310278327223	0.142410254682429	1277/1281/1289/1909/6678/7004/7058/7291	8
WP5087	Malignant pleural mesothelioma	109/1485	381/6033	0.036753185166285	0.173310278327223	0.142410254682429	72/9510/177/84962/10000/285/467/672/834/6347/6351/898/29126/960/1009/1014/1001/1003/1004/1029/1282/1284/1286/1437/1440/115908/1496/2919/3627/6374/80319/22943/1942/1946/1969/2246/2255/2259/2247/2252/2254/2261/2321/2324/8061/2305/11211/1839/3082/3091/3620/3586/3553/3569/3672/3673/3655/3685/3689/3690/3791/9493/284217/3909/3910/3911/3913/3915/3918/10319/26524/51176/9064/11184/9448/4323/4313/4314/4318/114548/5155/5159/5163/5228/5293/5328/5420/10891/9770/83593/6401/5176/6423/6425/6513/8140/64321/6678/6772/6788/7004/7010/7015/29128/7424/7480/7481/7472/7474	109
WP534	Glycolysis and gluconeogenesis	15/1485	39/6033	0.0381857066899766	0.178526338114677	0.146696327095097	229/230/2023/2026/2203/3099/3101/3939/5105/5214/5313/5315/6513/6514/6515	15
WP5083	Neuroinflammation and glutamatergic signaling	37/1485	115/6033	0.0394211168225139	0.182740261880637	0.150158937406008	816/27185/2247/2892/2893/2898/2906/116443/3458/3586/3587/3552/3553/3554/3569/3572/84230/80131/4049/4791/26227/23236/5579/29968/6505/6507/6509/6513/6515/92745/9021/6772/6774/7042/7043/7124/7133	37
WP75	Toll-like receptor signaling pathway	28/1485	84/6033	0.0440751233930304	0.202597415932669	0.166475698264697	10000/841/6348/6351/958/941/942/3627/6373/4283/3455/3553/3569/23643/1326/5600/6300/5293/8503/23533/6696/6772/7096/7097/7099/51311/54106/7124	28
WP5122	Prostaglandin and leukotriene metabolism in senescence 	11/1485	27/6033	0.0473019425429287	0.21561802142485	0.177174819875707	246/240/10800/3488/5600/23236/5730/9536/5740/5743/6916	11
WP2881	Estrogen receptor pathway	6/1485	12/6033	0.0505993656237193	0.225023195090849	0.184903116143159	51/1545/8431/5105/5166/6774	6
WP5112	Familial hyperlipidemia type 5	6/1485	12/6033	0.0505993656237193	0.225023195090849	0.184903116143159	335/337/1071/3949/3990/4023	6
WP5188	Retinol metabolism	6/1485	12/6033	0.0505993656237193	0.225023195090849	0.184903116143159	316/54905/1551/10170/9227/195814	6
WP727	Monoamine transport	9/1485	21/6033	0.0510634334791495	0.225255629944313	0.185094109470262	183/273/3553/3554/3690/6532/6999/7124/4982	9
WP2855	Dopaminergic neurogenesis	7/1485	15/6033	0.0522643510960255	0.228708800396208	0.187931603520024	1644/4009/4760/4821/4929/6469/6774	7
WP2406	Cardiac progenitor differentiation	12/1485	31/6033	0.0576051199927768	0.250079370127372	0.205491948512245	290/22943/2247/3624/3670/3791/83881/3084/5080/5460/64321/7070	12
WP236	Adipogenesis	36/1485	115/6033	0.0605969158011912	0.260996164907493	0.214462354306744	183/651/1051/1675/1271/56603/1879/1959/2487/3091/3569/3572/8609/23175/4023/83881/10135/7025/5008/5105/80339/10891/5618/5740/6258/6319/5054/8651/9021/6772/6774/6776/7124/57761/7291/7480	36
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	18/1485	52/6033	0.0678967723406587	0.286754916134193	0.235628498391803	308/602/332/79092/2113/2149/3309/3315/8870/3575/1728/3084/8767/9021/7124/7185/10451/7431	18
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	18/1485	52/6033	0.0678967723406587	0.286754916134193	0.235628498391803	10000/898/1003/1277/1278/2321/3082/3791/4313/4318/4791/5361/5362/91584/55630/6615/7042/7043	18
WP3591	Sleep regulation	9/1485	22/6033	0.0681501628838117	0.286754916134193	0.235628498391803	100/134/1141/51738/3606/3569/22871/5729/5730	9
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	5/1485	10/6033	0.0735398371085017	0.305666206791294	0.251168036755283	1116/3572/4318/9021/6774	5
WP3413	NOTCH1 regulation of endothelial cell calcification	7/1485	16/6033	0.0737622290611532	0.305666206791294	0.251168036755283	249/813/2261/2702/3672/4256/55553	7
WP554	ACE inhibitor pathway	6/1485	13/6033	0.0749278011682177	0.308161708564023	0.25321860782611	1636/59272/183/185/3827/4846	6
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	8/1485	20/6033	0.0941182235410762	0.384199016992304	0.315698990196697	332/3315/3569/3791/4318/6696/6774/7099	8
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	21/1485	65/6033	0.0986338005449667	0.39964954739331	0.328394797915796	947/22943/147409/1959/94234/2619/3458/3488/26085/5653/5650/51176/4488/4772/22822/864/25928/6925/8626/7474/7704	21
WP5111	Familial hyperlipidemia type 4	7/1485	17/6033	0.099709742595131	0.401038449996593	0.329536068793506	335/337/1071/3949/3990/4023/4547	7
WP2197	Endothelin pathways	10/1485	27/6033	0.103675694191283	0.413946019873223	0.340142308257223	10203/1906/1909/2769/10681/51764/4846/4852/23236/5739	10
WP12	Osteoclast signaling	6/1485	14/6033	0.104748825576407	0.415200055002133	0.341172757598212	1513/8111/3690/5155/6696/4982	6
WP4008	NO/cGMP/PKG mediated neuroprotection	12/1485	34/6033	0.108187282184104	0.423277176876231	0.34780978452064	816/1259/1261/2906/2977/3458/3553/4843/4846/4881/5593/7124	12
WP5052	Nephrogenesis	5/1485	11/6033	0.10833419517856	0.423277176876231	0.34780978452064	8854/80000/130497/284654/84870	5
WP3646	Hepatitis C and hepatocellular carcinoma	16/1485	48/6033	0.10970545892592	0.425594936400554	0.34971430355631	330/332/672/960/1284/3577/2487/3091/3569/51176/4312/4843/5420/5743/6241/6774	16
WP1539	Angiogenesis	9/1485	24/6033	0.111840577162499	0.430822504985118	0.354009832827183	2247/2321/3091/3791/4318/4846/5155/7010/7078	9
WP3925	Amino acid metabolism	24/1485	77/6033	0.114611488821223	0.438408981714749	0.360243693240061	126/440/445/586/875/1644/84706/3034/3067/3158/3939/4128/4357/4942/4953/5009/5105/5166/5315/5831/6723/6999/7166/7173	24
WP4496	Signal transduction through IL1R	11/1485	31/6033	0.117287532144678	0.445529722799574	0.366094855451589	3552/3553/3554/3556/3557/3569/3656/11213/7042/7043/7124	11
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	8/1485	21/6033	0.1206134789638	0.455003951677233	0.373879894864194	941/942/3101/3122/3586/3939/5210/6515	8
WP4136	Fibrin complement receptor 3 signaling pathway	12/1485	35/6033	0.129458806218069	0.483587358712367	0.397367078168346	6347/3627/2921/3569/3656/3684/3689/23643/4843/83593/7099/7124	12
WP3877	MYD88 distinct input-output pathway	7/1485	18/6033	0.129958577204238	0.483587358712367	0.397367078168346	3552/92610/7096/7097/7099/51311/54106	7
WP4747	Netrin-UNC5B signaling pathway	15/1485	46/6033	0.138254046519248	0.507925269711731	0.417365708009062	249/6347/1003/1277/2534/3383/3586/3552/3635/3791/59277/54538/6401/7124/7412	15
WP4900	Purinergic signaling	9/1485	25/6033	0.138356243486377	0.507925269711731	0.417365708009062	134/5027/27334/53829/9934/5030/5031/286530/24145	9
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	5/1485	12/6033	0.149573359146303	0.545444183020186	0.448195258634888	2222/2224/3157/3422/4597	5
WP4595	Urea cycle and associated pathways	8/1485	22/6033	0.150592516723794	0.545523885085531	0.44826075037337	8659/445/162417/4843/4846/4942/5009/5831	8
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	20/1485	65/6033	0.155360592385934	0.559093710757274	0.459411170005496	816/941/9076/1286/1378/1514/22943/1759/2534/3685/3690/3911/3913/4288/4311/4868/5329/5420/7099/7431	20
WP286	IL-3 signaling pathway	15/1485	47/6033	0.159186071800601	0.567024618419839	0.46592805169878	1232/969/942/1439/2534/3055/3563/3568/3635/3717/4067/5293/6774/6776/7409	15
WP4746	Thyroid hormones production and peripheral downstream signaling effects	24/1485	80/6033	0.159637643942697	0.567024618419839	0.46592805169878	10000/364/1734/1735/50506/405753/3685/3690/389434/152831/57224/4881/4852/23236/10891/5593/27330/6469/6567/5172/7038/7068/7173/7253	24
WP299	Nuclear receptors in lipid metabolism and toxicity	9/1485	26/6033	0.167770211083457	0.58452423861561	0.480307610678082	5243/1244/64240/1594/1559/1576/9971/9970/5915	9
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	9/1485	26/6033	0.167770211083457	0.58452423861561	0.480307610678082	2254/2261/3549/5600/6300/5745/5744/6615/6772	9
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	9/1485	26/6033	0.167770211083457	0.58452423861561	0.480307610678082	1390/2555/2557/2562/2564/2568/3717/8503/6774	9
WP4239	Epithelial to mesenchymal transition in colorectal cancer	38/1485	134/6033	0.179096221337945	0.616920439895722	0.506927793390693	10000/8999/9076/5010/24146/51208/9075/137075/9073/1282/1284/1286/56648/2305/94234/11211/3091/3678/26524/5600/6300/4313/4318/4854/4855/8828/5293/8503/6615/6678/7042/7043/7291/7480/7481/7472/7474/6935	38
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	6/1485	16/6033	0.179324222931298	0.616920439895722	0.506927793390693	2534/3122/3123/3569/64386/7535	6
WP2361	Gastric cancer network 1	8/1485	23/6033	0.183757814328006	0.624320027561612	0.513008085766975	6790/144455/1894/11082/4605/6286/22974/11065	8
WP5064	7-oxo-C and 7-beta-HC pathways	8/1485	23/6033	0.183757814328006	0.624320027561612	0.513008085766975	134526/23597/8309/23600/1593/1717/2053/3290	8
WP1434	Osteopontin signaling	5/1485	13/6033	0.196226832882607	0.654488277968207	0.537797545833588	3685/3690/4318/5328/6696	5
WP5176	Disorders of bile acid synthesis and biliary transport	5/1485	13/6033	0.196226832882607	0.654488277968207	0.537797545833588	1244/8309/23600/1593/9420	5
WP5178	Disorders of fructose metabolism	5/1485	13/6033	0.196226832882607	0.654488277968207	0.537797545833588	229/2203/3795/6514/6652	5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	14/1485	45/6033	0.197519277676737	0.654806332661668	0.538058893575545	695/6356/2534/3055/3559/3569/3575/3717/4067/4791/6772/6774/6775/6776	14
WP5222	2q13 copy number variation syndrome	15/1485	49/6033	0.20563072250059	0.67607312209998	0.555533961583165	55289/150468/1437/3552/3553/3554/3556/3557/51561/3569/284958/5336/8651/9021/6772	15
WP4298	Acute viral myocarditis	23/1485	79/6033	0.208746459104524	0.67607312209998	0.555533961583165	834/841/857/1232/1604/941/1906/2534/3108/3458/3586/3569/3683/3689/4318/4791/64127/5880/8651/6772/6774/7099/7124	23
WP2374	Oncostatin M signaling pathway	19/1485	64/6033	0.208973929285897	0.67607312209998	0.555533961583165	6347/1051/3091/3572/3717/3718/3726/3949/4312/4322/4314/5008/9180/5579/5054/9021/6772/6774/7078	19
WP4018	Clear cell renal cell carcinoma pathways	24/1485	83/6033	0.213106239805864	0.67607312209998	0.555533961583165	229/230/2023/2026/2321/3091/3099/3101/3791/8844/3939/4199/5155/5159/5214/26227/5313/5315/29968/6513/6774/7042/7043/6935	24
WP2064	Neural crest differentiation	20/1485	68/6033	0.214449424027646	0.67607312209998	0.555533961583165	1004/1302/1280/2113/2247/2261/51564/23493/3670/4359/4488/4791/4854/4855/283659/6615/6663/6925/7020/7291	20
WP1423	Ganglio sphingolipid metabolism	4/1485	10/6033	0.215043158280656	0.67607312209998	0.555533961583165	6482/6483/8869/6489	4
WP2436	Dopamine metabolism	4/1485	10/6033	0.215043158280656	0.67607312209998	0.555533961583165	1644/4128/4129/1728	4
WP4389	Bile acids synthesis and enterohepatic circulation 	4/1485	10/6033	0.215043158280656	0.67607312209998	0.555533961583165	64240/64241/3949/6555	4
WP364	IL6 signaling pathway	13/1485	42/6033	0.215057994964162	0.67607312209998	0.555533961583165	183/3055/3569/3572/3659/3717/3726/639/9021/6772/6774/7076/7409	13
WP5036	Angiotensin II receptor type 1 pathway	8/1485	24/6033	0.21971643291076	0.686770793155348	0.564324311897111	59272/183/185/1277/1278/3091/3589/3572	8
WP2324	AGE/RAGE pathway	19/1485	65/6033	0.231118568440229	0.718306005322758	0.59023701389939	177/249/841/3091/3625/3717/4322/4323/4313/4316/4318/4478/653361/4843/4846/5579/6772/6774/6776	19
WP4561	Cell migration and invasion through p75NTR	9/1485	28/6033	0.234166455460638	0.723666955576095	0.594642143810243	11093/10000/1009/1942/1946/4313/4318/6774/7291	9
WP4823	Genes controlling nephrogenesis	10/1485	32/6033	0.246159515063882	0.742501250466136	0.610118414219264	2118/2296/6928/8516/3791/3913/4868/5155/5159/6469	10
WP1602	Nicotine effect on dopaminergic neurons	5/1485	14/6033	0.247047948052718	0.742501250466136	0.610118414219264	1136/1141/1644/3777/84152	5
WP3935	Leptin-insulin signaling overlap	5/1485	14/6033	0.247047948052718	0.742501250466136	0.610118414219264	3717/8503/8651/9021/6774	5
WP3971	OSX and miRNAs in tooth development	5/1485	14/6033	0.247047948052718	0.742501250466136	0.610118414219264	249/22943/407024/4854/4855	5
WP58	Monoamine GPCRs	5/1485	14/6033	0.247047948052718	0.742501250466136	0.610118414219264	147/150/1131/3274/3363	5
WP2873	Aryl hydrocarbon receptor pathway	11/1485	36/6033	0.256293641555318	0.761916423536733	0.62607199624783	23491/1545/2939/3458/3553/3726/1728/8140/7124/54657/54578	11
WP4564	Neural crest cell migration during development	11/1485	36/6033	0.256293641555318	0.761916423536733	0.62607199624783	10000/1009/2047/2151/4313/4318/5293/8503/23533/6774/7291	11
WP4658	Small cell lung cancer	26/1485	93/6033	0.259624016354382	0.767645064572145	0.630779260218042	10000/330/841/898/1030/1282/1284/1286/3673/3655/3685/284217/3909/3910/3911/3913/3915/3918/10319/4843/5293/8503/5743/5915/6258/7185	26
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	17/1485	59/6033	0.268844190218134	0.782294200091798	0.642816556218989	84433/940/915/1437/1493/2534/29851/3458/3586/3702/3937/1326/5133/5163/5788/7124/7535	17
WP4760	PKC-gamma calcium signaling pathway in ataxia	6/1485	18/6033	0.269146166069873	0.782294200091798	0.642816556218989	773/2769/2892/2893/5163/23236	6
WP5149	Lipid metabolism in senescent cells	6/1485	18/6033	0.269146166069873	0.782294200091798	0.642816556218989	240/84647/50487/283748/7941/5743	6
WP69	T-cell receptor signaling pathway	24/1485	86/6033	0.273880319343114	0.782294200091798	0.642816556218989	84433/940/915/9308/2534/29851/3601/3605/3552/3553/3569/3662/3702/3937/1326/11184/4772/8767/3604/7409/10451/7431/7454/7535	24
WP3930	EDA signaling in hair follicle development	4/1485	11/6033	0.276019708624711	0.782294200091798	0.642816556218989	22943/1896/6469/25928	4
WP4629	Aerobic glycolysis	4/1485	11/6033	0.276019708624711	0.782294200091798	0.642816556218989	2023/3939/5315/6513	4
WP5049	Glycolysis in senescence	4/1485	11/6033	0.276019708624711	0.782294200091798	0.642816556218989	230/2023/3939/5315	4
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	4/1485	11/6033	0.276019708624711	0.782294200091798	0.642816556218989	2358/1241/5163/5293	4
WP2118	Arrhythmogenic right ventricular cardiomyopathy	17/1485	60/6033	0.294863978557485	0.826554615084683	0.679185645417415	775/9254/785/1496/1674/2697/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/51176	17
WP241	One-carbon metabolism	8/1485	26/6033	0.298107300782606	0.826554615084683	0.679185645417415	10840/275/55349/2346/2745/25902/10797/6948	8
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	5/1485	15/6033	0.30070268446408	0.826554615084683	0.679185645417415	23086/84958/94120/94122/201294	5
WP4159	GABA receptor signaling	5/1485	15/6033	0.30070268446408	0.826554615084683	0.679185645417415	2555/2557/2562/2564/2568	5
WP4842	Mammalian disorder of sexual development	5/1485	15/6033	0.30070268446408	0.826554615084683	0.679185645417415	84733/2254/5600/5730/284654	5
WP698	Glucuronidation	5/1485	15/6033	0.30070268446408	0.826554615084683	0.679185645417415	54575/54657/54578/79799/7364	5
WP2839	Hair follicle development: organogenesis - part 2 of 3	9/1485	30/6033	0.308207592580509	0.838753995729047	0.689209960889643	1896/2246/3624/3911/51176/6469/6615/8626/7474	9
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	9/1485	30/6033	0.308207592580509	0.838753995729047	0.689209960889643	59272/3455/10379/4939/4940/6772/7097/7099/54106	9
WP5053	Development of ureteric collection system	15/1485	53/6033	0.313420219203699	0.843311536276142	0.692954923486795	653/2118/2296/80144/2719/80000/6928/8516/4613/5915/6091/6469/7042/57216/7481	15
WP1591	Heart development	10/1485	34/6033	0.3164870881523	0.843311536276142	0.692954923486795	8553/2255/2296/2627/23493/3670/4772/5308/6469/7424	10
WP289	Myometrial relaxation and contraction pathways	35/1485	131/6033	0.317312423704702	0.843311536276142	0.692954923486795	196883/133/467/800/816/1265/2697/2784/59345/10681/51764/2786/2869/2980/2981/3485/3486/3488/3553/3569/23764/4846/5142/5333/5336/5577/5579/10266/10268/5996/6004/64407/10287/5999/8490	35
WP3599	Transcription factor regulation in adipogenesis	6/1485	19/6033	0.317590816220997	0.843311536276142	0.692954923486795	1051/3569/23175/10891/7124/7291	6
WP5066	FOXA2 pathway	6/1485	19/6033	0.317590816220997	0.843311536276142	0.692954923486795	1244/338/2938/2939/51085/4547	6
WP4917	Proximal tubule transport	12/1485	42/6033	0.329281318178883	0.867774880785987	0.713056622910837	5243/1244/9429/6560/6505/6513/6514/142680/6519/8671/340024/11136	12
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	7/1485	23/6033	0.329976554302533	0.867774880785987	0.713056622910837	185/285/2022/2200/2316/4053/5054	7
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4/1485	12/6033	0.339242883363915	0.879459038862851	0.72265757643498	8061/6776/7076/7431	4
WP4792	Purine metabolism	4/1485	12/6033	0.339242883363915	0.879459038862851	0.72265757643498	100/3614/4860/7498	4
WP5171	Leukotriene metabolic pathway	4/1485	12/6033	0.339242883363915	0.879459038862851	0.72265757643498	4363/240/1800/22949	4
WP4816	TGF-beta receptor signaling in skeletal dysplasias	15/1485	54/6033	0.342566065880074	0.883885085077361	0.726294489229353	81794/25805/2022/2200/3458/3624/3694/51176/864/5054/6498/6696/6772/6774/7124	15
WP4241	Type 2 papillary renal cell carcinoma	9/1485	31/6033	0.347050920172911	0.891252832556723	0.732348618304091	253559/81578/1513/112399/3091/5155/6513/7042/7043	9
WP4558	Overview of interferons-mediated signaling pathway	5/1485	16/6033	0.355874712433527	0.909642372435231	0.747459430443267	3455/3458/10379/3717/6772	5
WP4565	Neural crest cell migration in cancer	11/1485	39/6033	0.358316654327997	0.91162423217402	0.749087938301369	10000/1009/2047/2151/4313/4318/5293/8503/23533/6774/7291	11
WP26	S1P receptor signal transduction	7/1485	24/6033	0.375377780757968	0.941888284745911	0.773956119669978	10000/6300/23236/1901/9294/1903/8877	7
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	7/1485	24/6033	0.375377780757968	0.941888284745911	0.773956119669978	196883/2769/4935/23236/5579/5176/7306	7
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	7/1485	24/6033	0.375377780757968	0.941888284745911	0.773956119669978	1636/59272/183/3606/3569/114548/7124	7
WP2583	T cell receptor and co-stimulatory signaling	8/1485	28/6033	0.381622907860568	0.948853320907867	0.779679338069199	940/1493/2534/3702/5133/5163/10125/7535	8
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	8/1485	28/6033	0.381622907860568	0.948853320907867	0.779679338069199	9509/1277/1278/60681/4015/5034/5176/4982	8
WP3995	Prion disease pathway	9/1485	32/6033	0.386530165650356	0.952396399147499	0.782590709970138	10538/1879/2534/7184/3309/3662/5452/6688/6774	9
WP3998	Prader-Willi and Angelman syndrome	9/1485	32/6033	0.386530165650356	0.952396399147499	0.782590709970138	57194/990/1029/1030/9638/2562/51738/4948/5122	9
WP2267	Synaptic vesicle pathway	12/1485	44/6033	0.396413630711092	0.972368860981916	0.799002220031325	773/10814/1759/26052/22999/246213/6570/6507/6532/6616/2054/6857	12
WP395	IL-4 signaling pathway	14/1485	52/6033	0.400607658910536	0.974932071412809	0.801108427774982	332/1051/9046/2316/3635/3717/3718/5600/5293/8651/9021/6772/6774/6776	14
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	4/1485	13/6033	0.402805572466718	0.974932071412809	0.801108427774982	249/3655/7015/7124	4
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	4/1485	13/6033	0.402805572466718	0.974932071412809	0.801108427774982	56624/3091/1901/1903	4
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	5/1485	17/6033	0.411343216316387	0.986862891776596	0.810912065406729	9595/51176/3371/7412/7472	5
WP5074	Kallmann syndrome	5/1485	17/6033	0.411343216316387	0.986862891776596	0.810912065406729	23129/60675/9723/6663/26022	5
WP383	Striated muscle contraction pathway	6/1485	21/6033	0.417012551306026	0.991913159753345	0.815061905541573	1674/7134/7125/7169/7171/7431	6
WP205	IL-7 signaling pathway	7/1485	25/6033	0.42102330293461	0.991913159753345	0.815061905541573	2534/3559/3575/3718/6772/6774/6776	7
WP4950	16p11.2 distal deletion syndrome	7/1485	25/6033	0.42102330293461	0.991913159753345	0.815061905541573	718/3732/8519/3717/3791/5350/7185	7
WP581	EPO receptor signaling	7/1485	25/6033	0.42102330293461	0.991913159753345	0.815061905541573	3717/5163/5788/8651/6772/6774/6776	7
WP408	Oxidative stress response	8/1485	29/6033	0.423980169917862	0.991913159753345	0.815061905541573	1536/3726/4128/4501/1728/6648/54578/7498	8
WP4756	Renin-angiotensin-aldosterone system (RAAS)	9/1485	33/6033	0.426222124942795	0.991913159753345	0.815061905541573	1636/183/185/57118/816/64764/84699/9586/3283	9
WP4148	Splicing factor NOVA regulated synaptic proteins	10/1485	37/6033	0.427955220661407	0.991913159753345	0.815061905541573	288/23705/1600/1946/2036/2037/2898/3763/22854/2054	10
WP4331	Neovascularisation processes	10/1485	37/6033	0.427955220661407	0.991913159753345	0.815061905541573	2324/3091/3791/4318/4791/4854/4855/5155/7042/7043	10
WP3611	Photodynamic therapy-induced AP-1 survival signaling	13/1485	49/6033	0.431233197297879	0.992657250680179	0.815673330203861	602/890/898/1029/2252/1839/3458/3569/3726/5600/6300/4313/7124	13
WP585	Interferon type I signaling pathways	14/1485	53/6033	0.431905714189913	0.992657250680179	0.815673330203861	2534/3455/10379/27250/5293/5788/8651/9021/6772/6774/6775/6776/7409/7535	14
WP185	Integrin-mediated cell adhesion	24/1485	94/6033	0.457365660100727	0.999999999999959	0.821706918117931	10000/11131/827/857/2534/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/6300/5880/7145/10451/7791	24
WP3656	Interleukin-1 induced activation of NF-kB	3/1485	10/6033	0.462858112884059	0.999999999999959	0.821706918117931	84962/3552/92610	3
WP4846	SARS-CoV-2 and COVID-19 pathway	3/1485	10/6033	0.462858112884059	0.999999999999959	0.821706918117931	59272/1514/340024	3
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	3/1485	10/6033	0.462858112884059	0.999999999999959	0.821706918117931	718/629/1675	3
WP560	TGF-beta receptor signaling	13/1485	50/6033	0.463737991454909	0.999999999999959	0.821706918117931	25805/2022/3458/3624/3694/51176/864/5054/6498/6696/6772/6774/7124	13
WP4584	Biomarkers for pyrimidine metabolism disorders	4/1485	14/6033	0.465108622232319	0.999999999999959	0.821706918117931	1152/51251/6241/1890	4
WP5061	Fatty acid transporters	4/1485	14/6033	0.465108622232319	0.999999999999959	0.821706918117931	2180/2182/2168/2172	4
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/1485	18/6033	0.466034389488123	0.999999999999959	0.821706918117931	308/1280/2252/3490/1728	5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5/1485	18/6033	0.466034389488123	0.999999999999959	0.821706918117931	1014/1004/6615/3371/7431	5
WP3927	BMP signaling in eyelid development	5/1485	18/6033	0.466034389488123	0.999999999999959	0.821706918117931	2255/2296/3625/5308/6469	5
WP4533	Transcription co-factors SKI and SKIL protein partners	5/1485	18/6033	0.466034389488123	0.999999999999959	0.821706918117931	26524/23314/6498/6788/7004	5
WP4875	Disruption of postsynaptic signaling by CNV	7/1485	26/6033	0.466308145832717	0.999999999999959	0.821706918117931	816/1740/2906/9456/22871/57555/9378	7
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	6/1485	22/6033	0.466339058548994	0.999999999999959	0.821706918117931	1244/9429/2052/5600/6300/1728	6
WP4537	Hippo-Yap signaling pathway	6/1485	22/6033	0.466339058548994	0.999999999999959	0.821706918117931	3627/26524/11184/9448/6788/7004	6
WP4673	Male infertility	25/1485	100/6033	0.503009061866255	0.999999999999959	0.821706918117931	5243/27161/338/675/1191/56603/94240/2346/3122/4057/4313/4318/4843/4846/1728/55124/29968/9985/113235/6648/6948/7124/9319/10537/7516	25
WP34	Ovarian infertility	6/1485	23/6033	0.514467001224215	0.999999999999959	0.821706918117931	1051/2701/5618/23224/7783/7784	6
WP1584	Type II diabetes mellitus	5/1485	19/6033	0.51904995136924	0.999999999999959	0.821706918117931	773/3651/23533/6514/7124	5
WP2895	Differentiation of white and brown adipocyte	5/1485	19/6033	0.51904995136924	0.999999999999959	0.821706918117931	1051/253738/27129/51316/10891	5
WP325	Triacylglyceride synthesis	5/1485	19/6033	0.51904995136924	0.999999999999959	0.821706918117931	56895/2819/3990/4023/80168	5
WP5194	Synthesis of ceramides and 1-deoxyceramides	5/1485	19/6033	0.51904995136924	0.999999999999959	0.821706918117931	53947/2683/1674/259230/8877	5
WP1946	Cori cycle	4/1485	15/6033	0.524892599602587	0.999999999999959	0.821706918117931	3939/5214/6513/6514	4
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/1485	15/6033	0.524892599602587	0.999999999999959	0.821706918117931	1051/2939/1728/23657	4
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4/1485	15/6033	0.524892599602587	0.999999999999959	0.821706918117931	699/701/991/1062	4
WP5101	Congenital generalized lipodystrophy (CGL)	4/1485	15/6033	0.524892599602587	0.999999999999959	0.821706918117931	857/2534/3091/23175	4
WP3630	NAD metabolism, sirtuins and aging	3/1485	11/6033	0.532922514481315	0.999999999999959	0.821706918117931	3091/10135/6098	3
WP4271	Vitamin B12 disorders	3/1485	11/6033	0.532922514481315	0.999999999999959	0.821706918117931	8029/6947/6948	3
WP4963	p53 transcriptional gene network	20/1485	81/6033	0.536754474384024	0.999999999999959	0.821706918117931	8659/6790/6347/898/126129/6376/54541/55332/144455/3383/10379/9636/4688/5366/5371/5268/5054/6513/23657/7124	20
WP3940	One-carbon metabolism and related pathways	10/1485	40/6033	0.538337020613583	0.999999999999959	0.821706918117931	64902/586/587/23743/55349/56994/29958/1759/2882/6648	10
WP4222	Phosphodiesterases in neuronal function	10/1485	40/6033	0.538337020613583	0.999999999999959	0.821706918117931	196883/1139/2906/2977/10846/5153/5137/5142/5145/84152	10
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	9/1485	36/6033	0.542741488519405	0.999999999999959	0.821706918117931	684/3429/8519/10581/10410/3726/5600/6300/6196	9
WP3298	Melatonin metabolism and effects	8/1485	32/6033	0.547797225713947	0.999999999999959	0.821706918117931	1545/1557/1565/1906/4128/406938/4543/6817	8
WP4542	Leukocyte-intrinsic Hippo pathway functions	8/1485	32/6033	0.547797225713947	0.999999999999959	0.821706918117931	50943/3683/26524/4023/639/83593/6788/7004	8
WP4481	Resistin as a regulator of inflammation	7/1485	28/6033	0.553717196530426	0.999999999999959	0.821706918117931	10000/3569/5293/23236/5333/5336/7124	7
WP4655	Cytosolic DNA-sensing pathway	14/1485	57/6033	0.554981094475572	0.999999999999959	0.821706918117931	9447/834/843/841/6351/9560/3627/3606/3553/90865/3569/9636/10622/81030	14
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	12/1485	49/6033	0.563282544368936	0.999999999999959	0.821706918117931	27161/1051/1513/8091/3726/51176/4128/4129/6696/7042/4982/7480	12
WP2355	Corticotropin-releasing hormone signaling pathway	19/1485	78/6033	0.564946687129819	0.999999999999959	0.821706918117931	1393/8061/2697/2784/10681/3283/3606/3726/3861/4846/3164/4929/5336/5579/10411/6822/6925/7020/7099	19
WP3580	Methionine de novo and salvage pathway	5/1485	20/6033	0.569677138973837	0.999999999999959	0.821706918117931	51074/55349/259307/4953/6723	5
WP3640	Imatinib and chronic myeloid leukemia	5/1485	20/6033	0.569677138973837	0.999999999999959	0.821706918117931	5243/9429/2321/5159/11040	5
WP3645	NAD+ biosynthetic pathways	5/1485	20/6033	0.569677138973837	0.999999999999959	0.821706918117931	952/3620/10135/23475/6999	5
WP4224	Purine metabolism and related disorders	5/1485	20/6033	0.569677138973837	0.999999999999959	0.821706918117931	100/316/3614/4860/7498	5
WP2332	Interleukin-11 signaling pathway	10/1485	41/6033	0.573506214104226	0.999999999999959	0.821706918117931	332/2534/3383/3589/3572/3673/3717/9021/6772/6774	10
WP5220	Metabolic reprogramming in pancreatic cancer	10/1485	41/6033	0.573506214104226	0.999999999999959	0.821706918117931	587/3099/3158/3939/3949/4199/5315/6566/6513/8140	10
WP4217	Ebola virus infection in host	30/1485	124/6033	0.578761453892193	0.999999999999959	0.821706918117931	432/684/857/11314/93978/1514/2316/2318/3108/3112/3119/3122/3123/3134/3384/3672/3673/3678/3655/3685/3690/4240/4791/5293/8503/9021/6772/7020/91937/7099	30
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	4/1485	16/6033	0.581231895325608	0.999999999999959	0.821706918117931	3157/3949/10891/6319	4
WP22	IL-9 signaling pathway	4/1485	16/6033	0.581231895325608	0.999999999999959	0.821706918117931	3718/6772/6774/6776	4
WP3644	NAD+ metabolism	4/1485	16/6033	0.581231895325608	0.999999999999959	0.821706918117931	952/10135/23057/349565	4
WP368	Mitochondrial long chain fatty acid beta-oxidation	4/1485	16/6033	0.581231895325608	0.999999999999959	0.821706918117931	35/80221/2180/2182	4
WP4225	Pyrimidine metabolism and related diseases	4/1485	16/6033	0.581231895325608	0.999999999999959	0.821706918117931	51251/5009/6241/1890	4
WP1601	Fluoropyrimidine activity	7/1485	29/6033	0.594997159543515	0.999999999999959	0.821706918117931	9429/8824/6241/7083/1890/7371/7378	7
WP4211	Transcriptional cascade regulating adipogenesis	3/1485	12/6033	0.597482391520448	0.999999999999959	0.821706918117931	1051/1959/10365	3
WP5223	2q21.1 copy number variation syndrome	3/1485	12/6033	0.597482391520448	0.999999999999959	0.821706918117931	205147/50649/6774	3
WP536	Calcium regulation in cardiac cells	30/1485	125/6033	0.598698032059577	0.999999999999959	0.821706918117931	196883/147/773/775/777/811/816/1131/2697/2701/2702/127534/2709/10052/2784/59345/10681/51764/2786/2869/3760/5350/5577/5579/5996/6004/64407/10287/5999/8490	30
WP4630	Measles virus infection	28/1485	117/6033	0.604482892061633	0.999999999999959	0.821706918117931	841/898/940/915/3310/3455/3552/3553/3559/3560/3569/10379/3718/4478/4791/4939/4940/5293/8503/6504/6772/6774/6776/7097/7099/54106/7128/7161	28
WP1528	Physiological and pathological hypertrophy of the heart	6/1485	25/6033	0.60497958159034	0.999999999999959	0.821706918117931	183/1906/3572/5600/5579/6774	6
WP304	Kit receptor signaling pathway	14/1485	59/6033	0.612933249546331	0.999999999999959	0.821706918117931	695/2534/3635/3717/3726/4067/5579/10603/6615/8651/6772/6774/6776/7409	14
WP5072	Modulators of TCR signaling and T cell activation	14/1485	59/6033	0.612933249546331	0.999999999999959	0.821706918117931	84433/940/915/921/3702/3937/1326/11184/399/4068/8651/7128/7409/7535	14
WP4758	Nephrotic syndrome	9/1485	38/6033	0.615122903208657	0.999999999999959	0.821706918117931	54443/8542/1286/1493/8029/2262/3913/4868/5420	9
WP262	Ebstein-Barr virus LMP1 signaling	5/1485	21/6033	0.617384822620028	0.999999999999959	0.821706918117931	6364/4791/9260/7124/7185	5
WP170	Nuclear receptors	8/1485	34/6033	0.623924187121744	0.999999999999959	0.821706918117931	9970/7025/3164/4929/5915/6097/6258/7068	8
WP3286	Copper homeostasis	12/1485	51/6033	0.625096988973336	0.999999999999959	0.821706918117931	8754/4489/4493/4494/4495/4496/4500/4501/4502/4504/79689/54739	12
WP3874	Canonical and non-canonical TGF-B signaling	4/1485	17/6033	0.633505335020753	0.999999999999959	0.821706918117931	26585/4015/4016/4017	4
WP4784	Proteoglycan biosynthesis	4/1485	17/6033	0.633505335020753	0.999999999999959	0.821706918117931	9469/22856/55790/1836	4
WP4912	SARS coronavirus and innate immunity	4/1485	17/6033	0.633505335020753	0.999999999999959	0.821706918117931	59272/3455/10379/6772	4
WP4149	White fat cell differentiation	7/1485	30/6033	0.634233033202524	0.999999999999959	0.821706918117931	1051/1879/1959/3662/10365/6776/7480	7
WP4787	Osteoblast differentiation and related diseases	23/1485	98/6033	0.643022139076572	0.999999999999959	0.821706918117931	2246/2255/2247/2252/2254/2261/11211/23493/3549/5600/6300/4854/4855/5288/5293/8503/23533/5579/6772/7480/7481/7472/7474	23
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	3/1485	13/6033	0.655885437236566	0.999999999999959	0.821706918117931	8309/4312/5743	3
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	3/1485	13/6033	0.655885437236566	0.999999999999959	0.821706918117931	3685/3690/7134	3
WP3958	GPR40 pathway	3/1485	13/6033	0.655885437236566	0.999999999999959	0.821706918117931	23236/5333/5336	3
WP692	Sulfation biotransformation reaction	3/1485	13/6033	0.655885437236566	0.999999999999959	0.821706918117931	6817/6799/6822	3
WP2371	Parkinson's disease pathway	8/1485	35/6033	0.659256933398283	0.999999999999959	0.821706918117931	898/1644/120892/5600/6300/9627/23208/9246	8
WP357	Fatty acid biosynthesis	5/1485	22/6033	0.661810047346803	0.999999999999959	0.821706918117931	2180/2182/1891/55268/6319	5
WP1742	TP53 network	4/1485	18/6033	0.681354176601504	0.999999999999959	0.821706918117931	1029/5366/8626/7161	4
WP2525	Trans-sulfuration and one-carbon metabolism	6/1485	27/6033	0.685405980304674	0.999999999999959	0.821706918117931	275/875/25902/10797/26227/29968	6
WP2643	Nanoparticle-mediated activation of receptor signaling	6/1485	27/6033	0.685405980304674	0.999999999999959	0.821706918117931	10000/1277/3672/5600/6300/5293	6
WP3869	Cannabinoid receptor signaling	6/1485	27/6033	0.685405980304674	0.999999999999959	0.821706918117931	1557/1559/1576/5600/6300/5577	6
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	6/1485	27/6033	0.685405980304674	0.999999999999959	0.821706918117931	1959/3315/26353/4359/5865/79628	6
WP5121	Sphingolipid metabolism in senescence	6/1485	27/6033	0.685405980304674	0.999999999999959	0.821706918117931	23236/5579/1901/9294/8877/7015	6
WP2272	Pathogenic Escherichia coli infection	11/1485	49/6033	0.69089975596021	0.999999999999959	0.821706918117931	10095/9076/2534/3059/23643/7099/79861/7280/10381/84617/7454	11
WP4255	Non-small cell lung cancer	16/1485	71/6033	0.702268916227889	0.999999999999959	0.821706918117931	10000/841/1029/1381/1382/3718/5163/5293/8503/5336/5579/5915/83593/6258/6774/6776	16
WP5205	Clock-controlled autophagy in bone metabolism	16/1485	71/6033	0.702268916227889	0.999999999999959	0.821706918117931	393/8553/651/653/8646/115908/1513/22943/3569/3717/4772/10507/5176/4982/7480/7474	16
WP4357	NRF2-ARE regulation	5/1485	23/6033	0.702738671269744	0.999999999999959	0.821706918117931	1051/2534/2939/1728/23657	5
WP4483	Relationship between inflammation, COX-2 and EGFR	5/1485	23/6033	0.702738671269744	0.999999999999959	0.821706918117931	10000/4312/5293/51365/5743	5
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	5/1485	23/6033	0.702738671269744	0.999999999999959	0.821706918117931	3553/3569/10135/23057/6513	5
WP4540	Hippo signaling regulation pathways	19/1485	84/6033	0.705390194038817	0.999999999999959	0.821706918117931	1009/1014/1001/1003/1004/1969/2261/2321/2324/3791/26524/51176/5159/23236/5577/5579/6788/7004/7010	19
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	3/1485	14/6033	0.70791547769227	0.999999999999959	0.821706918117931	1466/283120/5366	3
WP49	IL-2 signaling pathway	9/1485	41/6033	0.711404866011548	0.999999999999959	0.821706918117931	2534/3559/3560/3718/9111/9021/6772/6774/6776	9
WP2870	Extracellular vesicle-mediated signaling in recipient cells	6/1485	28/6033	0.721321103152196	0.999999999999959	0.821706918117931	3082/4240/23533/7042/7043/7474	6
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	4/1485	19/6033	0.724635303330108	0.999999999999959	0.821706918117931	3091/3939/5163/6513	4
WP4961	STING pathway in Kawasaki-like disease and COVID-19	4/1485	19/6033	0.724635303330108	0.999999999999959	0.821706918117931	2152/2212/3553/114548	4
WP5181	Roles of ceramides in the development of insulin resistance	4/1485	19/6033	0.724635303330108	0.999999999999959	0.821706918117931	2180/3651/7124/7185	4
WP244	Alpha 6 beta 4 signaling pathway	7/1485	33/6033	0.737809224784918	0.999999999999959	0.821706918117931	3655/284217/3909/3911/3913/3915/3918	7
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	9/1485	42/6033	0.739749491209394	0.999999999999959	0.821706918117931	330/841/6347/3569/4318/4791/7124/51330/7185	9
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	9/1485	42/6033	0.739749491209394	0.999999999999959	0.821706918117931	72/3689/3690/3694/11184/9448/259230/6788/7004	9
WP4925	Unfolded protein response	5/1485	24/6033	0.740083038784686	0.999999999999959	0.821706918117931	841/3309/3553/5366/7494	5
WP1992	Genes targeted by miRNAs in adipocytes	2/1485	10/6033	0.747415018359629	0.999999999999959	0.821706918117931	2078/2697	2
WP2007	Iron metabolism in placenta	2/1485	10/6033	0.747415018359629	0.999999999999959	0.821706918117931	30061/7036	2
WP2333	Trans-sulfuration pathway	2/1485	10/6033	0.747415018359629	0.999999999999959	0.821706918117931	875/4357	2
WP4259	Disorders of folate metabolism and transport	2/1485	10/6033	0.747415018359629	0.999999999999959	0.821706918117931	10840/113235	2
WP5050	TCA cycle in senescence	2/1485	10/6033	0.747415018359629	0.999999999999959	0.821706918117931	4199/5163	2
WP382	MAPK signaling pathway	48/1485	210/6033	0.750581228681056	0.999999999999959	0.821706918117931	10000/773/775/777/9254/785/994/11221/1844/1846/1849/2246/2255/2259/2247/2252/2254/2261/2316/2318/3310/3315/3552/3553/3554/120892/9064/1326/11184/9448/5600/6300/22808/4772/4791/3164/5155/5159/283748/5778/5880/10125/25780/115727/6788/7042/7043/7124	48
WP5182	Pro-survival signaling of neuroprotectin D1	3/1485	15/6033	0.753671197214691	0.999999999999959	0.821706918117931	330/841/7124	3
WP3972	PDGFR-beta pathway	6/1485	29/6033	0.754275175397939	0.999999999999959	0.821706918117931	3717/5159/5579/6772/6774/6776	6
WP5117	Cohesin complex - Cornelia de Lange syndrome	6/1485	29/6033	0.754275175397939	0.999999999999959	0.821706918117931	9212/113130/983/157570/5347/9985	6
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	17/1485	78/6033	0.758973836415838	0.999999999999959	0.821706918117931	467/80319/22943/8061/11211/283120/51176/5328/5176/6423/6425/64321/7020/7480/7481/7472/7474	17
WP2878	PPAR-alpha pathway	4/1485	20/6033	0.763374844419176	0.999999999999959	0.821706918117931	335/345/983/2168	4
WP1971	Integrated cancer pathway	9/1485	43/6033	0.766137069028414	0.999999999999959	0.821706918117931	641/672/841/994/983/1030/4312/5347/6772	9
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	9/1485	43/6033	0.766137069028414	0.999999999999959	0.821706918117931	10000/775/816/2906/116443/9456/5293/8503/85358	9
WP4223	Ras signaling	36/1485	161/6033	0.776230403358471	0.999999999999959	0.821706918117931	10000/1969/2113/2261/2321/2324/2784/59345/10681/51764/2786/3363/3791/8844/283455/22808/5159/5293/8503/51365/84647/5320/50487/283748/5336/5579/5880/8437/64926/10125/25780/115727/83593/25759/7010/7535	36
WP127	IL-5 signaling pathway	8/1485	39/6033	0.77939345346694	0.999999999999959	0.821706918117931	695/1439/3568/3717/4067/6772/6774/6776	8
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	14/1485	66/6033	0.782168036096245	0.999999999999959	0.821706918117931	2222/2224/3157/3422/3638/3949/23175/4023/4047/4597/6319/10802/9871/6713	14
WP3858	Toll-like receptor signaling related to MyD88	6/1485	30/6033	0.784285710946792	0.999999999999959	0.821706918117931	4791/7096/7097/7099/51311/54106	6
WP254	Apoptosis	18/1485	84/6033	0.788943722627182	0.999999999999959	0.821706918117931	330/332/834/843/841/1029/3002/8739/3659/3662/4049/5366/5551/7124/7133/8626/7161/7185	18
WP4815	Glycosaminoglycan degradation	3/1485	16/6033	0.793464882266017	0.999999999999959	0.821706918117931	10855/3373/8692	3
WP4970	Galanin receptor pathway	3/1485	16/6033	0.793464882266017	0.999999999999959	0.821706918117931	3569/10891/7020	3
WP3527	Pre-implantation embryo	7/1485	35/6033	0.794354485763161	0.999999999999959	0.821706918117931	366/55509/11189/94234/3662/5460/7004	7
WP3679	Cell-type dependent selectivity of CCK2R signaling	2/1485	11/6033	0.795080019221477	0.999999999999959	0.821706918117931	952/23236	2
WP4589	Major receptors targeted by epinephrine and norepinephrine	2/1485	11/6033	0.795080019221477	0.999999999999959	0.821706918117931	196883/150	2
WP4788	Autosomal recessive osteopetrosis pathways	2/1485	11/6033	0.795080019221477	0.999999999999959	0.821706918117931	29887/10312	2
WP4919	Neuroinflammation	2/1485	11/6033	0.795080019221477	0.999999999999959	0.821706918117931	4843/7099	2
WP4947	Nitric oxide metabolism in cystic fibrosis	2/1485	11/6033	0.795080019221477	0.999999999999959	0.821706918117931	4843/4846	2
WP4288	MTHFR deficiency	4/1485	21/6033	0.797725437783681	0.999999999999959	0.821706918117931	55349/56994/2906/259230	4
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	4/1485	21/6033	0.797725437783681	0.999999999999959	0.821706918117931	841/5600/6300/7124	4
WP3941	Oxidative damage response	8/1485	40/6033	0.803958209276921	0.999999999999959	0.821706918117931	715/716/717/721/728/7124/7133/7185	8
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	5/1485	26/6033	0.804163162789378	0.999999999999959	0.821706918117931	857/1051/3717/5618/23508	5
WP3851	TLR4 signaling and tolerance	5/1485	26/6033	0.804163162789378	0.999999999999959	0.821706918117931	3569/3635/11213/7099/7124	5
WP2018	RANKL/RANK signaling pathway	11/1485	54/6033	0.810648496635165	0.999999999999959	0.821706918117931	1513/2274/3383/4067/4772/4791/6688/6772/4982/7185/7412	11
WP4844	Influence of laminopathies on Wnt signaling	6/1485	31/6033	0.811425673530103	0.999999999999959	0.821706918117931	27161/1051/8091/51176/6696/7480	6
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	6/1485	31/6033	0.811425673530103	0.999999999999959	0.821706918117931	3283/4318/5163/5293/23236/5579	6
WP710	DNA damage response (only ATM dependent)	22/1485	103/6033	0.811940928938241	0.999999999999959	0.821706918117931	10000/604/1029/8061/3949/51176/197259/4791/5163/5288/5293/8503/23533/5328/5366/5880/6648/7161/7480/7481/7472/7474	22
WP4290	Metabolic reprogramming in colon cancer	8/1485	41/6033	0.82639538340186	0.999999999999959	0.821706918117931	229/2023/3101/3939/5315/29968/5831/6513	8
WP4830	GDNF/RET signaling axis	3/1485	17/6033	0.827741928104288	0.999999999999959	0.821706918117931	2296/26585/64321	3
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	4/1485	22/6033	0.827928857880765	0.999999999999959	0.821706918117931	597/10017/3655/5744	4
WP4806	EGFR tyrosine kinase inhibitor resistance	17/1485	82/6033	0.828744570794856	0.999999999999959	0.821706918117931	10000/2247/2261/3082/3569/3717/3791/22808/3084/5155/5159/5293/8503/5336/5579/25759/6774	17
WP3931	Embryonic stem cell pluripotency pathways	19/1485	91/6033	0.830148807831217	0.999999999999959	0.821706918117931	90/10000/2246/2255/2259/2247/2252/2254/2261/3572/6300/5155/5159/5293/6774/7480/7481/7472/7474	19
WP2533	Glycerophospholipid biosynthetic pathway	5/1485	27/6033	0.831153431535902	0.999999999999959	0.821706918117931	56994/2819/23175/5293/5320	5
WP2857	Mesodermal commitment pathway	26/1485	122/6033	0.831676153144309	0.999999999999959	0.821706918117931	90/92/8728/10973/57198/8553/55704/8646/1466/22943/2296/2627/8091/3624/3717/51176/83881/5080/5308/5460/5915/6615/64321/6925/55809/10451	26
WP2513	Nanoparticle triggered regulated necrosis	2/1485	12/6033	0.834599544761682	0.999999999999959	0.821706918117931	841/7124	2
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/1485	12/6033	0.834599544761682	0.999999999999959	0.821706918117931	22943/6750	2
WP4504	Cysteine and methionine catabolism	2/1485	12/6033	0.834599544761682	0.999999999999959	0.821706918117931	875/4357	2
WP5173	Disorders of galactose metabolism 	2/1485	12/6033	0.834599544761682	0.999999999999959	0.821706918117931	8908/6514	2
WP23	B cell receptor signaling pathway	20/1485	96/6033	0.838016007966056	0.999999999999959	0.821706918117931	604/695/84433/973/27071/2113/2534/3059/3635/3662/7462/4067/11184/118788/5336/5579/5788/5880/25780/7409	20
WP3303	RAC1/PAK1/p38/MMP2 pathway	13/1485	65/6033	0.844848329915894	0.999999999999959	0.821706918117931	285/9068/332/9046/5600/6300/4313/4843/6774/6776/7010/7075/79931	13
WP3658	Wnt/beta-catenin signaling pathway in leukemia	4/1485	23/6033	0.85428468664098	0.999999999999959	0.821706918117931	22943/51176/5371/7704	4
WP3845	Canonical and non-canonical Notch signaling	4/1485	23/6033	0.85428468664098	0.999999999999959	0.821706918117931	51176/4237/4854/4855	4
WP3982	miRNA regulation of p53 pathway in prostate cancer	4/1485	23/6033	0.85428468664098	0.999999999999959	0.821706918117931	841/192668/5366/5054	4
WP5038	Mitochondrial immune response to SARS-CoV-2	5/1485	28/6033	0.855030024662795	0.999999999999959	0.821706918117931	1636/59272/185/1514/4791	5
WP3888	VEGFA-VEGFR2 signaling pathway	92/1485	409/6033	0.86269671436557	0.999999999999959	0.821706918117931	23597/8754/9510/56999/301/81575/22899/10973/332/811/813/857/6347/1003/79094/1397/1466/1536/1558/22943/4189/1847/1960/2022/1969/2078/2113/2152/2274/24147/2321/6624/2534/2697/1839/51564/3142/3315/5654/10525/3383/3486/3490/3685/3690/3791/9079/3939/3984/6300/4319/4323/4313/79812/653361/4688/91624/4772/4846/4855/3164/4929/8013/441478/8828/5034/55872/5228/5328/5329/4860/9588/5579/5743/57381/27289/1901/57758/6386/23753/6401/9047/25759/357/6541/6648/6748/6772/6774/7004/8794/81567	92
WP4942	15q13.3 copy number variation syndrome	2/1485	13/6033	0.867093018857158	0.999999999999959	0.821706918117931	1139/2534	2
WP4666	Hepatitis B infection	28/1485	134/6033	0.867959042509004	0.999999999999959	0.821706918117931	10000/332/843/841/64764/84699/9586/1959/1960/3569/3717/3718/5600/6300/4318/4772/5293/8503/5579/6772/6774/6775/6776/7042/7043/7097/7099/7124	28
WP4698	Vitamin D-sensitive calcium signaling in depression	5/1485	29/6033	0.87602061825964	0.999999999999959	0.821706918117931	775/1593/1594/2906/7166	5
WP2828	Bladder cancer	7/1485	39/6033	0.879015338666553	0.999999999999959	0.821706918117931	1029/2261/1839/4312/4313/4318/1890	7
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	14/1485	72/6033	0.879428471382461	0.999999999999959	0.821706918117931	80319/22943/8061/11211/51176/5328/5176/6423/6425/64321/7480/7481/7472/7474	14
WP5224	2q37 copy number variation syndrome	21/1485	104/6033	0.8808547401861	0.999999999999959	0.821706918117931	10123/10203/1058/1293/6373/27128/27185/55355/3553/79781/3690/547/129807/5133/3651/64284/25992/7124/54575/54657/54578	21
WP4722	Glycerolipids and glycerophospholipids	3/1485	19/6033	0.881841511231358	0.999999999999959	0.821706918117931	56895/56994/80339	3
WP5103	Progeria-associated lipodystrophy	3/1485	19/6033	0.881841511231358	0.999999999999959	0.821706918117931	2200/3763/5965	3
WP51	Regulation of actin cytoskeleton	26/1485	127/6033	0.886482630357654	0.999999999999959	0.821706918117931	50649/9459/1131/81624/2149/2246/2255/2259/2247/2252/2254/2261/3672/3984/22808/4478/5155/5159/5288/5293/8503/23533/5880/7409/7429/7454	26
WP47	Hedgehog signaling pathway	2/1485	14/6033	0.893622609051306	0.999999999999959	0.821706918117931	3549/6469	2
WP53	ID signaling pathway	2/1485	14/6033	0.893622609051306	0.999999999999959	0.821706918117931	898/2004	2
WP143	Fatty acid beta-oxidation	5/1485	30/6033	0.894367599722209	0.999999999999959	0.821706918117931	35/2180/2182/3990/4023	5
WP2363	Gastric cancer network 2	5/1485	30/6033	0.894367599722209	0.999999999999959	0.821706918117931	1297/79075/51316/255488/11065	5
WP3915	Angiopoietin-like protein 8 regulatory pathway	25/1485	125/6033	0.908192911095555	0.999999999999959	0.821706918117931	64240/64241/1576/1734/2203/4023/9064/1326/11184/9448/5600/6300/51085/5105/5288/5293/8503/23433/6196/27330/6319/25759/6567/6513/7068	25
WP314	Fas ligand pathway and stress induction of heat shock proteins	7/1485	41/6033	0.909047964157613	0.999999999999959	0.821706918117931	397/843/841/3315/3552/8767/7124	7
WP1772	Apoptosis modulation and signaling	16/1485	84/6033	0.909741928384761	0.999999999999959	0.821706918117931	597/10017/330/332/664/834/843/841/1029/8739/3554/8682/5366/5783/8794/7133	16
WP428	Wnt signaling	19/1485	98/6033	0.911003977403679	0.999999999999959	0.821706918117931	816/80319/22943/8061/11211/51176/4772/5328/23236/5579/5176/6423/6425/64321/57216/7480/7481/7472/7474	19
WP2037	Prolactin signaling pathway	14/1485	75/6033	0.913033171600004	0.999999999999959	0.821706918117931	2316/2534/3659/3717/4843/5618/6196/8651/9021/6772/6774/6776/7409/7535	14
WP1422	Sphingolipid pathway	4/1485	26/6033	0.913636859183955	0.999999999999959	0.821706918117931	56624/9514/259230/8877	4
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/1485	15/6033	0.915153595487708	0.999999999999959	0.821706918117931	2254/5600	2
WP4962	Airway smooth muscle cell contraction	2/1485	15/6033	0.915153595487708	0.999999999999959	0.821706918117931	952/23236	2
WP4905	1q21.1 copy number variation syndrome	3/1485	21/6033	0.920251052914362	0.999999999999959	0.821706918117931	2330/2697/2702	3
WP2516	ATM signaling pathway	6/1485	37/6033	0.9221690145796	0.999999999999959	0.821706918117931	8120/672/891/898/983/7161	6
WP2359	Parkin-ubiquitin proteasomal system pathway	11/1485	62/6033	0.925263155158663	0.999999999999959	0.821706918117931	834/841/898/3309/3310/9627/79861/7280/10381/84617/9246	11
WP3594	Circadian rhythm genes	32/1485	159/6033	0.925435329374601	0.999999999999959	0.821706918117931	100/134/56938/8553/1141/1390/1644/1960/2155/51738/50865/6928/9456/3363/3569/4543/4547/10135/22871/4843/5371/10891/5551/5593/60675/5730/6097/5054/150094/6532/7166/463	32
WP2112	IL-17 signaling pathway	4/1485	27/6033	0.927981803122747	0.999999999999959	0.821706918117931	1051/3605/3717/6774	4
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	2/1485	16/6033	0.932537697376521	0.999999999999959	0.821706918117931	51176/6925	2
WP500	Glycogen synthesis and degradation	6/1485	38/6033	0.93361298841136	0.999999999999959	0.821706918117931	8908/3099/3101/80201/5522/5523	6
WP399	Wnt signaling pathway and pluripotency	16/1485	87/6033	0.934825069148053	0.999999999999959	0.821706918117931	960/8061/11211/3949/51176/120892/4316/5328/5460/5522/5523/5579/7480/7481/7472/7474	16
WP4482	Vitamin D in inflammatory diseases	3/1485	22/6033	0.934828241603877	0.999999999999959	0.821706918117931	3569/4772/7124	3
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	5/1485	33/6033	0.935995278293122	0.999999999999959	0.821706918117931	3455/10379/4939/4940/6772	5
WP4150	Wnt signaling in kidney disease	4/1485	28/6033	0.940140432866072	0.999999999999959	0.821706918117931	7480/7481/7472/7474	4
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	1/1485	10/6033	0.940869398542181	0.999999999999959	0.821706918117931	672	1
WP5120	Inclusion body myositis	1/1485	10/6033	0.940869398542181	0.999999999999959	0.821706918117931	4791	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/1485	10/6033	0.940869398542181	0.999999999999959	0.821706918117931	51311	1
WP2038	Microtubule cytoskeleton regulation	7/1485	44/6033	0.942026067250421	0.999999999999959	0.821706918117931	9212/983/2151/11004/3984/6774/10420	7
WP410	Exercise-induced circadian regulation	7/1485	44/6033	0.942026067250421	0.999999999999959	0.821706918117931	1051/50486/2947/3108/3422/11030/10381	7
WP100	Glutathione metabolism	2/1485	17/6033	0.946510466612818	0.999999999999959	0.821706918117931	290/2938	2
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/1485	17/6033	0.946510466612818	0.999999999999959	0.821706918117931	3685/3690	2
WP3871	Valproic acid pathway	1/1485	11/6033	0.955448336474252	0.999999999999959	0.821706918117931	1559	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/1485	11/6033	0.955448336474252	0.999999999999959	0.821706918117931	604	1
WP4313	Ferroptosis	10/1485	61/6033	0.955620188218641	0.999999999999959	0.821706918117931	2180/2182/246/875/1536/1803/2222/3315/30061/23657	10
WP3584	MECP2 and associated Rett syndrome	9/1485	56/6033	0.955845866197557	0.999999999999959	0.821706918117931	604/2247/2289/2530/2892/2893/54715/6750/6890	9
WP4016	DNA IR-damage and cellular response via ATR	13/1485	76/6033	0.956563182751662	0.999999999999959	0.821706918117931	604/672/675/8318/983/63967/9156/2175/2305/5347/5371/353497/5965	13
WP466	DNA replication	6/1485	41/6033	0.959500127718325	0.999999999999959	0.821706918117931	8318/990/8317/55388/4998/23594	6
WP179	Cell cycle	21/1485	115/6033	0.959684127407868	0.999999999999959	0.821706918117931	699/890/891/898/8556/991/994/8318/990/8317/983/1029/1030/10459/4998/23594/9088/5347/7042/7043/7272	21
WP4906	3q29 copy number variation syndrome	8/1485	52/6033	0.962655270351711	0.999999999999959	0.821706918117931	84984/3091/375387/80235/8503/30061/123264/6776	8
WP2636	Common pathways underlying drug addiction	4/1485	31/6033	0.966235013843844	0.999999999999959	0.821706918117931	72/2892/2893/5579	4
WP186	Homologous recombination	1/1485	12/6033	0.966434590266304	0.999999999999959	0.821706918117931	675	1
WP2023	Cell differentiation - expanded index	1/1485	12/6033	0.966434590266304	0.999999999999959	0.821706918117931	6774	1
WP2290	RalA downstream regulated genes	1/1485	12/6033	0.966434590266304	0.999999999999959	0.821706918117931	5880	1
WP3933	Kennedy pathway from sphingolipids	1/1485	12/6033	0.966434590266304	0.999999999999959	0.821706918117931	56994	1
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/1485	19/6033	0.966620996480869	0.999999999999959	0.821706918117931	2683/8877	2
WP1403	AMP-activated protein kinase (AMPK) signaling	9/1485	58/6033	0.967138438492078	0.999999999999959	0.821706918117931	147/890/891/126129/5209/5293/8503/23236/55437	9
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	8/1485	53/6033	0.968029416846296	0.999999999999959	0.821706918117931	843/841/3627/3458/9636/5600/6300/7124	8
WP4321	Thermogenesis	17/1485	98/6033	0.968240577418324	0.999999999999959	0.821706918117931	2180/2182/196883/656/126129/64764/84699/9586/2641/152831/5600/6300/4881/10891/5593/6196/27330	17
WP4249	Hedgehog signaling pathway	5/1485	37/6033	0.968532573427731	0.999999999999959	0.821706918117931	91653/2619/64399/3549/6469	5
WP524	G13 signaling pathway	5/1485	37/6033	0.968532573427731	0.999999999999959	0.821706918117931	397/398/3984/5293/7454	5
WP2853	Endoderm differentiation	21/1485	118/6033	0.970965553205712	0.999999999999959	0.821706918117931	10973/57198/22943/1844/1846/1847/2627/6928/3915/51176/10459/83881/5460/5744/23682/64321/6772/30009/6925/55809/10451	21
WP2586	Aryl hydrocarbon receptor pathway	6/1485	43/6033	0.97124757503267	0.999999999999959	0.821706918117931	1545/4023/135112/1728/5743/7124	6
WP2507	Nanomaterial induced apoptosis	2/1485	20/6033	0.973718063466523	0.999999999999959	0.821706918117931	841/5551	2
WP4725	Sphingolipid metabolism overview	2/1485	20/6033	0.973718063466523	0.999999999999959	0.821706918117931	259230/8877	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	13/1485	80/6033	0.974302792995073	0.999999999999959	0.821706918117931	183/1906/2247/51564/3572/3084/5293/8503/5320/5579/6774/7124/7474	13
WP35	G protein signaling pathways	14/1485	85/6033	0.974352133218515	0.999999999999959	0.821706918117931	196883/9472/9465/2769/2784/10681/51764/2786/3760/5153/5137/5142/5577/5579	14
WP4657	22q11.2 copy number variation syndrome	15/1485	90/6033	0.974510624630703	0.999999999999959	0.821706918117931	8854/8659/8318/8646/9076/56603/2255/2296/4942/5308/5347/5625/6097/6469/7450	15
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	1/1485	13/6033	0.974713054550399	0.999999999999959	0.821706918117931	25939	1
WP5037	Riboflavin and CoQ disorders	1/1485	13/6033	0.974713054550399	0.999999999999959	0.821706918117931	55065	1
WP4971	Phosphoinositides metabolism	6/1485	44/6033	0.975861497314078	0.999999999999959	0.821706918117931	3635/5288/5293/23236/5333/5336	6
WP3996	Ethanol effects on histone modifications	3/1485	27/6033	0.977256249977276	0.999999999999959	0.821706918117931	126/8854/51564	3
WP5102	Familial partial lipodystrophy (FPLD)	3/1485	27/6033	0.977256249977276	0.999999999999959	0.821706918117931	10365/4023/5396	3
WP4932	7q11.23 copy number variation syndrome	14/1485	86/6033	0.977530521877008	0.999999999999959	0.821706918117931	64756/695/9076/2006/2200/7462/3984/51085/3084/5313/6616/9246/155382/7472	14
WP2526	PDGF pathway	5/1485	39/6033	0.978276888145689	0.999999999999959	0.821706918117931	5155/5159/6772/6774/7409	5
WP5085	Vasopressin-regulated water reabsorption	5/1485	39/6033	0.978276888145689	0.999999999999959	0.821706918117931	397/398/64764/84699/9586	5
WP4726	Sphingolipid metabolism: integrated pathway	2/1485	21/6033	0.979346169840435	0.999999999999959	0.821706918117931	259230/8877	2
WP4928	MAPK pathway in congenital thyroid cancer	1/1485	14/6033	0.980950781127253	0.999999999999959	0.821706918117931	8844	1
WP313	Hepatocyte growth factor receptor signaling	4/1485	34/6033	0.981396210213215	0.999999999999959	0.821706918117931	3082/3672/11184/6774	4
WP4312	Rett syndrome causing genes	5/1485	40/6033	0.982014031556442	0.999999999999959	0.821706918117931	3766/23314/85358/23224/6925	5
WP45	G1 to S cell cycle control	9/1485	62/6033	0.982260397856717	0.999999999999959	0.821706918117931	891/898/8318/983/1029/1030/84699/4998/23594	9
WP4659	Gastrin signaling pathway	18/1485	108/6033	0.983017920667139	0.999999999999959	0.821706918117931	302/330/332/960/1029/1113/9076/2534/51564/3067/3717/4316/8503/5743/5054/6774/6925/7032	18
WP4566	Translation inhibitors in chronically activated PDGFRA cells	6/1485	46/6033	0.983102162230279	0.999999999999959	0.821706918117931	10000/27250/5163/8503/11040/6196	6
WP4686	Leucine, isoleucine and valine metabolism	2/1485	22/6033	0.983797962664091	0.999999999999959	0.821706918117931	586/587	2
WP4262	Breast cancer pathway	22/1485	129/6033	0.985732124166215	0.999999999999959	0.821706918117931	10000/672/675/2246/2255/2247/2252/2254/2324/11211/23493/51176/4791/4854/4855/5293/8503/25759/7480/7481/7472/7474	22
WP3959	DNA IR-double strand breaks and cellular response via ATM	7/1485	53/6033	0.986894340483574	0.999999999999959	0.821706918117931	641/672/675/1029/9156/6788/7161	7
WP4205	MET in type 1 papillary renal cell carcinoma	7/1485	53/6033	0.986894340483574	0.999999999999959	0.821706918117931	10000/2113/3082/3718/5293/8503/6774	7
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	4/1485	36/6033	0.987637436080627	0.999999999999959	0.821706918117931	3488/5163/10891/8744	4
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/1485	30/6033	0.98824545784437	0.999999999999959	0.821706918117931	4846/5163/8503	3
WP195	IL-1 signaling pathway	7/1485	54/6033	0.989009579946696	0.999999999999959	0.821706918117931	6347/3552/3553/3554/3556/3656/11213	7
WP1545	miRNAs involved in DNA damage response	1/1485	16/6033	0.989191438949838	0.999999999999959	0.821706918117931	898	1
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	1/1485	16/6033	0.989191438949838	0.999999999999959	0.821706918117931	5105	1
WP481	Insulin signaling	27/1485	156/6033	0.98967524752433	0.999999999999959	0.821706918117931	30846/5167/9064/1326/11184/9448/5600/6300/5288/5293/8503/5579/5880/5967/57381/23433/6196/27330/10110/10603/25759/6513/6616/8651/9021/57761/7494	27
WP4521	Glycosylation and related congenital defects	2/1485	24/6033	0.990077677710852	0.999999999999959	0.821706918117931	2683/79644	2
WP231	TNF-alpha signaling pathway	14/1485	92/6033	0.990189455124347	0.999999999999959	0.821706918117931	330/841/6347/3569/8844/283455/1326/4791/5347/6401/7124/7128/7133/7185	14
WP2637	Interleukin-1 (IL-1) structural pathway	6/1485	49/6033	0.990257556199895	0.999999999999959	0.821706918117931	3552/3554/3556/3656/1326/5600	6
WP2261	Glioblastoma signaling pathways	12/1485	82/6033	0.990724152037651	0.999999999999959	0.821706918117931	10000/672/675/898/1029/1030/54206/5159/5288/5293/5336/5579	12
WP4155	Endometrial cancer	8/1485	61/6033	0.991450318593965	0.999999999999959	0.821706918117931	10000/1496/2246/2247/2261/51176/5293/8503	8
WP4674	Head and neck squamous cell carcinoma	10/1485	72/6033	0.991575695390617	0.999999999999959	0.821706918117931	84962/10000/841/1029/54541/2261/4791/23533/7015/8626	10
WP4861	Endoplasmic reticulum stress response in coronavirus infection	5/1485	44/6033	0.991724053404213	0.999999999999959	0.821706918117931	3309/26051/84152/79660/7494	5
WP391	Mitochondrial gene expression	1/1485	17/6033	0.991858999720902	0.999999999999959	0.821706918117931	10891	1
WP5200	Dravet syndrome	1/1485	17/6033	0.991858999720902	0.999999999999959	0.821706918117931	5600	1
WP3965	Lipid metabolism pathway	2/1485	25/6033	0.992252055235464	0.999999999999959	0.821706918117931	10000/5577	2
WP4022	Pyrimidine metabolism	11/1485	79/6033	0.993508275484476	0.999999999999959	0.821706918117931	1503/5167/953/956/56953/10622/6241/7083/1890/7371/7378	11
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	1/1485	18/6033	0.993868538519848	0.999999999999959	0.821706918117931	55872	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/1485	18/6033	0.993868538519848	0.999999999999959	0.821706918117931	22808	1
WP734	Serotonin receptor 4/6/7 and NR3C signaling	1/1485	18/6033	0.993868538519848	0.999999999999959	0.821706918117931	3363	1
WP3981	miRNA regulation of prostate cancer signaling pathways	3/1485	33/6033	0.9940270802309	0.999999999999959	0.821706918117931	10000/354/5159	3
WP4874	CAMKK2 pathway	3/1485	33/6033	0.9940270802309	0.999999999999959	0.821706918117931	1131/3383/7412	3
WP2446	Retinoblastoma gene in cancer	12/1485	86/6033	0.994993042108462	0.999999999999959	0.821706918117931	54443/890/891/898/994/8318/8317/983/24137/4998/6241/7272	12
WP400	p38 MAPK signaling pathway	3/1485	34/6033	0.995249422490676	0.999999999999959	0.821706918117931	3315/6772/7042	3
WP384	Apoptosis modulation by HSP70	1/1485	19/6033	0.995382290855347	0.999999999999959	0.821706918117931	841	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/1485	19/6033	0.995382290855347	0.999999999999959	0.821706918117931	10125	1
WP2795	Cardiac hypertrophic response	6/1485	53/6033	0.995446829996401	0.999999999999959	0.821706918117931	2247/51564/11184/3084/5320/7124	6
WP268	Notch signaling	4/1485	41/6033	0.995697329525508	0.999999999999959	0.821706918117931	151636/4242/4854/4855	4
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2/1485	28/6033	0.99633900494923	0.999999999999959	0.821706918117931	841/5153	2
WP366	TGF-beta signaling pathway	20/1485	130/6033	0.996452030162613	0.999999999999959	0.821706918117931	467/857/983/1030/1278/2113/50943/3673/3690/3726/11184/4312/4321/5163/5371/150094/6498/7015/3371/6935	20
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/1485	20/6033	0.996522513349495	0.999999999999959	0.821706918117931	3002	1
WP3878	ATM signaling in development and disease 	4/1485	42/6033	0.996533879504386	0.999999999999959	0.821706918117931	9212/699/983/3315	4
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	4/1485	42/6033	0.996533879504386	0.999999999999959	0.821706918117931	196883/23224/7042/7043	4
WP673	ErbB signaling pathway	11/1485	83/6033	0.996605333380588	0.999999999999959	0.821706918117931	10000/816/1839/3084/145957/5293/8503/5336/5579/25759/6776	11
WP363	Wnt signaling pathway	5/1485	49/6033	0.996991288924409	0.999999999999959	0.821706918117931	2697/51176/5579/6925/7010	5
WP2447	Amyotrophic lateral sclerosis (ALS)	3/1485	36/6033	0.997008217688563	0.999999999999959	0.821706918117931	834/5630/7124	3
WP4549	Fragile X syndrome	14/1485	101/6033	0.997443214588269	0.999999999999959	0.821706918117931	27161/7915/816/1029/1759/1979/54869/2534/80852/9456/4318/5163/23236/6566	14
WP707	DNA damage response	7/1485	62/6033	0.997478335145422	0.999999999999959	0.821706918117931	672/841/891/898/983/5366/5371	7
WP4685	Melanoma	7/1485	63/6033	0.99791726486467	0.999999999999959	0.821706918117931	10000/1029/2113/3791/5293/8503/25759	7
WP61	Notch signaling pathway	6/1485	57/6033	0.997927972174299	0.999999999999959	0.821706918117931	23493/3091/3717/4854/4855/6774	6
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	20/1485	134/6033	0.997959420204643	0.999999999999959	0.821706918117931	249/55816/1959/2534/2562/2892/3717/3738/3781/8844/84894/653361/4688/10603/25759/6696/6772/6774/6776/10451	20
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	1/1485	22/6033	0.998028157565942	0.999999999999959	0.821706918117931	51176	1
WP2034	Leptin signaling pathway	9/1485	75/6033	0.998042084838647	0.999999999999959	0.821706918117931	2534/3553/3557/3717/4846/5336/9021/6772/6774	9
WP4263	Pancreatic adenocarcinoma pathway	11/1485	87/6033	0.998265417618997	0.999999999999959	0.821706918117931	10000/9459/675/1029/5293/8503/5880/6772/6774/7042/7043	11
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	2/1485	31/6033	0.99828711197331	0.999999999999959	0.821706918117931	51564/4772	2
WP5180	DYRK1A	6/1485	58/6033	0.998304574204606	0.999999999999959	0.821706918117931	273/1759/2247/3092/26524/4772	6
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	8/1485	70/6033	0.99830725558453	0.999999999999959	0.821706918117931	10000/332/51176/5366/5743/5880/7042/7043	8
WP531	DNA mismatch repair	1/1485	23/6033	0.998515295482191	0.999999999999959	0.821706918117931	9156	1
WP437	EGF/EGFR signaling pathway	24/1485	157/6033	0.998555052967827	0.999999999999959	0.821706918117931	50807/6790/857/1759/9046/54206/2697/3635/3717/11184/4605/4846/5359/5579/7837/6196/9047/6456/6772/6774/6776/7291/7409/10451	24
WP183	Proteasome degradation	6/1485	59/6033	0.998614689490748	0.999999999999959	0.821706918117931	3134/3458/5684/5696/5698/5721	6
WP5202	Alstrom syndrome	2/1485	32/6033	0.998672775082007	0.999999999999959	0.821706918117931	84984/26052	2
WP1530	miRNA regulation of DNA damage response	7/1485	66/6033	0.99883653420322	0.999999999999959	0.821706918117931	672/841/891/898/983/5366/5371	7
WP4949	16p11.2 proximal deletion syndrome	7/1485	67/6033	0.999044400786861	0.999999999999959	0.821706918117931	283897/841/11151/8448/3486/4478/23475	7
WP1471	Target of rapamycin (TOR) signaling	2/1485	35/6033	0.999385666495027	0.999999999999959	0.821706918117931	54541/3422	2
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	6/1485	64/6033	0.999505367429583	0.999999999999959	0.821706918117931	898/3717/23236/6772/6774/7253	6
WP4204	Tumor suppressor activity of SMARCB1	1/1485	27/6033	0.999523048604696	0.999999999999959	0.821706918117931	1029	1
WP623	Oxidative phosphorylation	2/1485	36/6033	0.999525516424819	0.999999999999959	0.821706918117931	3002/56901	2
WP138	Androgen receptor signaling pathway	9/1485	85/6033	0.999695793476215	0.999999999999959	0.821706918117931	672/811/857/898/2274/2316/354/8431/6774	9
WP3676	BDNF-TrkB signaling	1/1485	29/6033	0.999729760563973	0.999999999999959	0.821706918117931	9456	1
WP722	Serotonin HTR1 group and FOS pathway	1/1485	29/6033	0.999729760563973	0.999999999999959	0.821706918117931	10125	1
WP4396	Nonalcoholic fatty liver disease	17/1485	137/6033	0.999892828090196	0.999999999999959	0.821706918117931	10000/841/6347/84701/3552/3553/3569/51085/56901/9971/5293/8503/5313/9021/7124/7412/7494	17
WP3651	Pathways affected in adenoid cystic carcinoma	4/1485	58/6033	0.9999084039854	0.999999999999959	0.821706918117931	672/93986/4613/29128	4
WP422	MAPK cascade	1/1485	33/6033	0.999913301282569	0.999999999999959	0.821706918117931	6300	1
WP2369	Histone modifications	1/1485	35/6033	0.999950909001019	0.999999999999959	0.821706918117931	80854	1
WP2059	Alzheimer's disease and miRNA effects	32/1485	229/6033	0.999980783740993	0.999999999999959	0.821706918117931	177/10000/775/841/1139/1536/22943/11211/2906/3552/3553/3569/3800/4023/407024/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7480/7481/7472/7474/7494	32
WP107	Translation factors	2/1485	49/6033	0.999984367642691	0.999999999999959	0.821706918117931	1917/1979	2
WP3680	Physico-chemical features and toxicity-associated pathways	3/1485	58/6033	0.999985998749382	0.999999999999959	0.821706918117931	11211/6776/7481	3
WP5124	Alzheimer's disease	31/1485	226/6033	0.999986325108896	0.999999999999959	0.821706918117931	177/10000/775/841/1139/1536/22943/11211/2906/3552/3553/3569/3800/4023/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7480/7481/7472/7474/7494	31
WP405	Eukaryotic transcription initiation	1/1485	41/6033	0.999991099847096	0.999999999999959	0.821706918117931	2966	1
WP4753	Nucleotide excision repair	1/1485	43/6033	0.999994964934912	0.999999999999959	0.821706918117931	2966	1
WP4656	Joubert syndrome	4/1485	71/6033	0.999995978777181	0.999999999999959	0.821706918117931	27077/2316/5145/6469	4
WP1541	Energy metabolism	1/1485	44/6033	0.999996213193953	0.999999999999959	0.821706918117931	10891	1
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	2/1485	57/6033	0.999998158395762	0.999999999999959	0.821706918117931	672/2966	2
WP4536	Genes related to primary cilium development (based on CRISPR)	4/1485	88/6033	0.999999942107558	0.999999999999959	0.821706918117931	27077/23552/84984/51715	4
WP4946	DNA repair pathways, full network	6/1485	112/6033	0.999999991729347	0.999999999999959	0.821706918117931	672/675/9156/2175/2187/2966	6
WP477	Cytoplasmic ribosomal proteins	2/1485	86/6033	0.999999999321823	0.999999999999959	0.821706918117931	6196/27330	2
WP4803	Ciliopathies	8/1485	139/6033	0.999999999498443	0.999999999999959	0.821706918117931	122481/27077/10309/84984/1259/1768/4751/51715	8
WP4352	Ciliary landscape	11/1485	201/6033	0.999999999999959	0.999999999999959	0.821706918117931	26286/875/9859/30845/128239/3934/55388/2040/7020/339488/7431	11
